Detailed Information

Research Field/Keywords for Research Field

• Tumor diagnosis

Education

• 1987/03, Graduated

Employment Experience

• 1987/06 - 1988/05
• 1988/06 - 1989/05
• 1989/06 - 1991/05
• 1991/06 - 1992/06
• 1992/07 - 1993/04
• 1993/05 - 1994/03
• 1994/04 - 1994/05
• 1994/06 - 1997/04
• 1997/05 - 1999/04
• 1999/05 - 1999/07
• 1999/08 - 2000/05
• 2000/06 - 2003/09 Research Associate
• 2003/10 - 2015/02 Lecturer, University Hospital, Faculty of Medicine, Saga University
• 2015/03 -  *  Associate Professor, Medicine, Faculty of Medicine, Saga University

Field of Specialization

• Respiratory organ internal medicine

Research Topics and Results

• Dysautonomia associated with immune checkpoint inhibitors 2023/07
• Response 2023/06
• Absence of copy number gain of EGFR: A possible predictive marker of long-term response to afatinib 2023/03
• Usefulness of blood biomarkers for predicting venous thromboembolism in Japanese patients with cancer 2023/03
• A 45-Year-Old Woman With Unexplained Iron Deficiency Anemia and No Respiratory Symptoms 2023/01
• Anti-cancer effect of afatinib, dual inhibitor of HER2 and EGFR, on novel mutation HER2 E401G in models of patient-derived cancer  2023/01
• Effect of Azithromycin on Exacerbations in Asthma Patients with Obesity: Protocol for a Multi-Center, Prospective, Single-Arm Intervention Study  2023/01
• Factors related to the diagnosis of lung cancer by transbronchial biopsy with endobronchial ultrasonography and a guide sheath 2022/12
• Obesity affects pulmonary function in Japanese adult patients with asthma, but not those without asthma 2022/09
• Real-World Data Analysis of Pembrolizumab Monotherapy for NSCLC Using Japanese Postmarketing All-Case Surveillance Data 2022/09
• Clinical utility of comprehensive genomic profiling in Japan: Result of PROFILE-F study  2022/03
• Anti-IL-5 Agents for the Treatment of Idiopathic Chronic Eosinophilic Pneumonia: A Case Series 2022/02
• Integrated approach to functional analysis of an ERBB2 variant of unknown significance detected by a cancer gene panel test  2022/02
• A 45-Year-Old Man With Acute Chest Pain, Fever, and Dyspnea After Tooth Extraction  2021/12
• Factors Associated with Reduction of Sedentary Time Following Tiotropium/Olodaterol Therapy in Treatment-Naïve Chronic Obstructive Pulmonary Disease 2021/12
• Current achievement and future perspective of genome profiling by liquid biopsy 2021/11
• Optimal Consideration for Maximal Clinical Benefits in Various EGFR-mutant Populations  2021/10
• Severity of constipation related to palonosetron during first-line chemotherapy: a retrospective observational study  2021/08
• Skeletal muscle is associated with exercise tolerance evaluated by cardiopulmonary exercise testing in Japanese patients with chronic obstructive pulmonary disease  2021/08
• The role of comprehensive analysis with circulating tumor DNA in advanced non-small cell lung cancer patients considered for osimertinib treatment  2021/06
• Effect of health locus of control on physical activity in stable patients with chronic obstructive pulmonary diseases  2021/06
• A phase 2 basket trial of combination therapy with trastuzumab and pertuzumab in patients with solid cancers harboring HER2 amplification (JUPITER trial)  2021/06
• ALDH2 polymorphism rs671 is a predictor of PD-1/PD-L1 inhibitor efficacy against thoracic malignancies  2021/05
• Idiopathic eosinophilic pleurisy: A practical diagnostic approach  2021/05
• Tiotropium/olodaterol reduces sedentary behavior in patients with treatment-na?ve chronic obstructive pulmonary disease 2021/05
• Clinical Manifestations of Allergic Bronchopulmonary Aspergillosis without Major Features of Asthma Diagnosed by the New Criteria in Japan 2021/04
• IMpower132: Atezolizumab plus platinum-based chemotherapy vs chemotherapy for advanced NSCLC in Japanese patients  2021/04
• A Low Body Mass Index Is Associated with Unsuccessful Treatment in Patients with Mycobacterium avium Complex Pulmonary Disease  2021/04
• Acute Generalized Exanthematous Pustulosis Caused by Erlotinib in a Patient with Lung Cancer  2021/03
• Efficacy of dupilumab and biomarkers for systemic corticosteroid naïve allergic bronchopulmonary mycosis 2021/01
• Evaluation of olfactory dysfunction to estimate the presence of eosinophilic chronic rhinosinusitis in patients with asthma 2021/01
• The clinical outcomes of nivolumab plus ipilimumab combined with platinum-based chemotherapy, single-center, retrospective analysis 2021
• Clinical features of Japanese patients with exacerbations of chronic obstructive pulmonary disease 2020/12
• Multiplex gene-panel testing for lung cancer patients 2020/12
• Biomarkers for Overweight in Adult-Onset Asthma 2020/10
• Review article Current achievements and future perspectives with liquid biopsy 2020/10
• First-Line Treatment with Tiotropium/Olodaterol Improves Physical Activity in Patients with Treatment-Naïve Chronic Obstructive Pulmonary Disease 2020/09
• Initial treatment with tiotropium/olodaterol improves physical inactivity in patients with treatment-naïve COPD 2020/09
• A phase 2 basket trial of combination therapy with trastuzumab and pertuzumab in patients with solid cancers harboring human epidermal growth factor receptor 2 amplification (JUPITER trial) 2020/08
• A rare case of Trichosporon mycotoxinivorans and Cryptococcus neoformans co-infection in lung 2020/08
• Targeting aberrant DNA hypermethylation as a driver of ATL leukemogenesis using the new oral demethylating agent OR-2100 2020/08
• Origin of circulating free DNA in patients with lung cancer 2020/07
• Clinical impact of advanced chronic kidney disease in patients with non-HIV pulmonary cryptococcosis 2020/04
• Invited Review Articles Significance of a Liquid Biopsy on Lung Cancer 2020/04
• Eosinophilic granulomatous polyangiitis with IgG4 hypergammaglobulinaemia and salivary gland swelling 2020/03
• The non-antibiotic macrolide EM900 attenuates HDM and poly(I:C)-induced airway inflammation with inhibition of macrophages in a mouse model 2020/01
• The Nonantibiotic Macrolide EM900 Attenuates House Dust Mite-Induced Airway Inflammation in a Mouse Model of Obesity-Associated Asthma 2020
• Association of Genetic Polymorphisms With Afatinib-induced Diarrhoea 2020
• Blood Eosinophils at the Stable Period are a Biomarker of Frequent Exacerbation for Japanese Patients with COPD 2020
• The Non-Antibiotic Macrolide EM900 attenuates HDM-induced airway inflammation in Obese Asthma Model 2020
• Tiotropium/olodaterol improves pulmonary function and physical activity in patients with treatment-naïve COPD 2020
• Microbiome contribute to increase pulmonary response to ozone in obese mice 2020
• Clinical characteristics and biomarker for Japanese asthmatic patients with obesity 2020
• Mesalazine-induced airway obstruction: Utility of pulmonary function testing in drug-induced lung diseases. 2019/11
• Discontinuation due to immune-related adverse events is a possible predictive factor for immune checkpoint inhibitors in patients with non-small cell lung cancer. 2019/09
• Paraneoplastic Limbic Encephalitis Complicated with Small Cell Lung Cancer at the Time of Recurrence. 2019/06
• Characteristics of circulating tumor DNA in lung cancer patients. 2019
• How does circulating turmor DNA exist in peripheral blood? 2019
• Investigation of mechanisms of acquired resistance to afatinib with plasma DNA in non-small cell lung cancer patients. 2019
• Analysis of a novel variant of HER2 detected by clinical sequencing in cancer of unknown primary 2019
• Analysis of a novel variant of extracellular domain of HER2 detected by clinical sequencing in cancer of unknown primary.  2019
• Prospective study for usefulness of plasma DNA on prediction of third generation EGFR tyrosine kinase inhibitors (S-PLAT study) 2019
• Prospective study for usefulness of plasma DNA on prediction of third generation EGFR tyrosine kinase inhibitors. 2019
• An effect of novel non-antibiotic macrolide EM900 in HDM-induced airway inflammation mice model 2019
• Tiotropium/olodaterol improves pulmonary function in patients with treatment naïve COPD 2019
• Identification of the BRAF V600E mutation in Japanese patients with hairy cell leukemia and related diseases using a quenching probe method.  2018
• Current Status and Problems of T790M Detection, a Molecular Biomarker of Acquired Resistance to EGFR Tyrosine Kinase Inhibitors, with Liquid Biopsy and Re-biopsy. 2018
• Mechanisms of acquired resistance to afatinib clarified with liquid biopsy 2018
• Automated DNA extraction using cellulose magnetic beads can improve EGFR point mutation detection with liquid biopsy by efficiently recovering short and long DNA fragments. 2018
• Anxiety and depression associated with tyrosine kinase inhibitor discontinuation in patients with chronic myeloid leukemia 2018
• Investigation of Appropriate Pre-analytical Procedure for Circulating Free DNA from Liquid Biopsy. 2018
• Relationship between the duration of trimethoprim/sulfamethoxazole treatment and the clinical outcome of pulmonary nocardiosis. 2018
• Phase II trial of gefitinib plus pemetrexed after relapse using first-line gefitinib in patients with non-small cell lung cancer harboring EGFR gene mutations. 2018
• A case of osimertinib-resistant lung adenocarcinoma responded effectively to alternating therapy. 2018
• Primary Pulmonary Colloid Adenocarcinoma: How Can We Obtain a Precise Diagnosis? 2018
• Successful Surgical Resection following Bronchial Artery Embolization in a Case of Lung Cancer Complicated with Massive Hemoptysis. 2018
• Necrotizing Sarcoid Granulomatosis with Natural Resolution after a Surgical Lung Biopsy. 2018
• Sj?gren Syndrome Complicated with Cystic Lung Disease and Pulmonary Amyloidosis.  2018
• Signet Ring Cell Carcinoma of Unknown Primary Complicated with Pulmonary Tumor Thrombotic Microangiopathy and Krukenberg Tumor.  2018
• Characteristics of circulating tumor DNA in lung cancer patients.  2018
• Circulating tumor DNA and tumor progression 2018
• Combination of liquid biopsy and re-biopsy for identification of genetic alterations related with acquired resistance to EGFR-TKI 2018
• Circulating tumor DNA and tumor progression 2018
• irAE, Possible Predictive Markers for Immune Checkpoint Inhibitors 2018
• Mechanisms of acquired resistance to afatinib clarified with liquid biopsy 2018
• Investigation of origin of circulating free DNA: Is exosomal DNA the carrier? 2018
• Investigation of origin of circulating free DNA: Is EV the carrier?  2018
• An Effect of Clarthromycin Treatment in HDM-Induced Allergic Airway Inflammation in Mice 2018
• Characteristics of circulating free DNA in lung cancer patients.  2018
• Analysis of a novel mutation of ERBB2 in cancer of unknown primary 2018
• Investigation of origin of circulating free DNA: Are extracellular vesicles the carrier? 2018
• Chemotherapy for primary mediastinal yolk sac tumor in a patient undergoing chronic hemodialysis: a case report. 2017
• Functional analysis of Discoidin domain receptor 2 mutation and expression in squamous cell lung cancer. 2017
• Severity and predictive factors of adverse events in pemetrexed-containing chemotherapy for non-small cell lung cancer. 2017
• Plasma T790M and HGF as potential predictive markers for EGFR-TKI re-challenge. 2017
• Thin-section CT findings of multicentric Castleman disease changing over 10 years. 2017
• Pre-existing chronic interstitial pneumonia is poor prognostic factor of Goodpasture's syndrome: a case and review of the literature 2017
• Saturated Fatty Acid Increases Lung Macrophages and Augments House Dust Mite-Induced Airway Inflammation in Mice Fed with High-Fat Diet. 2017
• Characteristics of cell free DNA in lung cancer patients. 2017
• Characteristics of cell free DNA in lung cancer patients. 2017
• Liquid biopsy for genomic alterations (Discussant). 2017
• Correlation and problems of re-biopsy and liquid biopsy for detecting T790M mutation. 2017
• Clarification of mechanisms of acquired resistance for afatinib using plasma samples. 2017
• DNA extraction method using cellulose magnetic beads can improve the EGFR mutation detection rate. 2017
• Automatic DNA extraction system can improve the EGFR point mutation detection rate of liquid biopsy. 2017
• Recruited lung macrophages contribute to progression of airway inflammation in obesity asthma mice model.  2017
• Successful treatment of pulmonary nocardiosis with Fluoroquinolone in bronchial asthma and bronchiectasis 2017
• Characteristics and prognosis of microscopic polyangiitis with bronchiectasis, Journal of Thoracic Disease 2017
• Mutation profile of B-raf gene analyzed by fully automated system and clinical features in Japanese melanoma patients 2017
• Detection of KRAS Mutations in plasma DNA using a fully automated rapid detection system in colorectal cancer patients 2017
• IL-33 from inflammatory monocytes recruited to lung contributes to HDM-Induced airway inflammation 2016
• A case of rapidly progressive primary mixed-type germ cell tumor of the mediastinum after induction chemotherapy 2016
• Functional analysis of Discoidin domain receptor 2 mutation and expression in squamous cell lung cancer 2016
• IL-33 from inflammatory monocytes recruited to lung contributes to HDM-Induced airway inflammation 2016
• Functional analysis of Discoidin domain receptor 2 mutation and expression in squamous cell lung cancer 2016
• An analysis of pulmonary manifestations of IgG4-Related Disease 2016
• Investigation of mechanism of lymphogenous metastasis using human lung cancer metastatic animal model 2016
• Investigation of mechanism of lymphogenous metastasis using human lung cancer metastatic animal model 2016
• A retrospective analysis of the efficacy and safety of ALK inhibitors in ALK-positive lung cancer patients 2016
• Coexistence of lung cancer and immunoglobulin G4-related lung disease in a nodule: a case report. 2016
• Chronic and Asymptomatic Diffuse Alveolar Haemorrhage with Microscopic Polyangiitis: A Case Report and Review of the Literature. 2016
• Interleukin-33 from monocytes recruited to the lung contributes to house dust mite-induced airway inflammation in a mouse model. 2016
• Monitoring EGFR T790M with plasma DNA from lung cancer patients in a prospective observational study. 2016
• Phase II trial of weekly nab-paclitaxel for previously treated advancednon–small cell lung cancer: Kumamoto thoracic oncology study group(KTOSG) trial 1301 2016
• SPARC is a Possible Predictive Marker for Albumin-bound Paclitaxel in Non-small Cell Lung Cancer. 2016
• Torin2 potentiates anti-cancer effects for adult T-cell leukemia/lymphoma by inhibiting mammalian target of rapamycin. 2016
• A case with cancer of unknown primary diagnosed pathologically retroperitoneal squamous cell carcinoma. 2015
• Evaluation of a cloud-based local-read paradigm for imaging evaluations in oncology clinical trials for lung cancer. 2015
• 2-Hydroxypropyl-β-cyclodextrin Acts as a Novel Anticancer Agent. 2015
• Failure mode and effects analysis of medication adherence in patients with chronic myeloid leukemia. 2015
• Volume-based response evaluations with consensual lesion selection using cloud solutions (SaaS) in clinical trials: a pilot study 2015
• For Hanshin-Saga Collaborative Cancer Study Group. Monitoring EGFR T790M with plasma DNA from lung cancer patients in a prospective observational study. 2015
• Usefulness of plasma HGF level for monitoring acquired resistance to EGFR tyrosine kinase inhibitors in non-small cell lung cancer 2015
• A case of relapsing polychondritis successfully treated with combination of a glucocorticoid and cyclosporine. 2015
• Monocytes IL-33 contributes to HDM-induced allergic airway inflammation 2015
• SPARC, a possible predictive marker to albumin-bound paclitaxel (nab-paclitaxel) in non-small cell lung cancer 2015
• Potential predictive markers for re-challenge with first generation and second generation EGFR-TKI 2015
• A case with cancer of unknown primary diagnosed pathologically retroperitoneal squamous cell carcinoma. 2015
• Correlation between plasma DNA and tumor status in an animal model.  2014
• Monitoring EGFR T790M with plasma DNA in lung cancer patients treated with EGFR tyrosine kinase inhibitor in prospective observation study. 2014
• Volume-based response evaluations with consensual lesion selection using cloud solutions in clinical trials: a pilot study 2014
• Usefulness of peripheral blood for monitoring of acquired resistance to EGFR tyrosine kinase inhibitors in non-small cell lung cancer 2014
• Monitoring of metastasis by detection of EGFR mutation, T790M, with plasma using animal model for metastasis of human lung cancer 2014
• Non-invasive monitoring system for acquired resistance to EGFR-tyrosine kinase inhibitors using circulating plasma DNA 2014
• Monitoring of EGFR T790M with plasma in lung cancer patients 2014
• Three cases of hemodialysis patients with advanced gastric cancer treated with Paclitaxel and nab paclitaxel 2014
• Diffuse bone marrow uptake of FDG in a patient with aleukemic acute lymphoblastic leukemia 2014
• Usefulness of peripheral blood for monitoring of acquired resistance to EGFR tyrosine kinase inhibitors. 2014
• SPARC, as a possible predictive marker for albumin-bound paclitaxel in non-small cell lung cancer 2014
• Correlation between plasma DNA and tumor status in an animal model on metastasis of lung cancer 2014
• A non-invasive system for monitoring resistance to EGFR tyrosine kinase inhibitors with plasma DNA. 2011/10
• Mina53, a Target Gene of C-Myc, is Favorable Prognostic Marker in Early Stage Lung Cancer. 2011/09
• A non-invasive system for monitoring resistance to EGFR tyrosine kinase inhibitors with plasma DNA. 2011/09
• A non-invasive system for monitoring resistance to EGFR tyrosine kinase inhibitors with plasma DNA. 2011/07
• A non-invasive system for monitoring resistance to EGFR tyrosine kinase inhibitors with plasma DNA. 2011/07
• Fully automated detection system of EGFR mutation, T790M with plasma DNA of lung cancer patients. 2011/07
• A Phase II Study of Erlotinib in Japanese EGFR Mutation Positive Patients with Pretreated Non-Small Cell Lung Cancer (NSCLC):Lung Oncology Group in Kyushu, Japan (LOGiK0803). 2011/07
• A non-invasive system for monitoring resistance to EGFR tyrosine kinase inhibitors with plasma DNA. 2011/06
• A non-invasive system for monitoring resistance to EGFR tyrosine kinase inhibitors with plasma DNA. 2011/06
• An Analysis Of Prognostic Factor For Diffuse Alveolar Hemorrhage Patients 2011/05
• Gene regulation induced by constitutive expression of hypoxia-inducible factor-1a in lymphocytes of transgenic mice. 2011/04
• Fully automated detection system of EGFR mutation, T790M with plasma DNA of lung cancer patients. 2011/04
• Dual targeting therapy on topoisomerase IIa and DNA-dependent protein kinase is a promising strategy for adult T cell leukemia-lymphoma. 2011/02
• A non-invasive system for monitoring resistance to EGFR tyrosine kinase inhibitors with plasma DNA. 2011/02
• NK314 potentiates anti-tumor activity with adult T-cell leukemia-lymphoma cells by inhibition of dual targets on topoisomerase IIα and DNA-dependent protein kinase. 2011
• Phase II study of gefitinib as a first-line therapy in elderly patients with pulmonary adenocarcinoma: West Japan Thoracic Oncology Group Study 0402. 2011
• A non-invasive system for monitoring resistance to EGFR tyrosine kinase inhibitors with plasma DNA. 2011
• A Fully Integrated and Automated Detection System for Single Nucleotide Polymorphisms of UGT1A1 and CYP2C19. 2011
• A fully integrated, automated and rapid detection system for KRAS mutations. 2011
• Mina53, a novel c-Myc target gene, is a favorable prognostic marker in early stage lung cancer 2010/09
• Fully automated detection system of EGFR mutation, T790M with plasma DNA of lung cancer patients. 2010/09
• Constitutive expression of Hypoxia-inducible factor-a alpha induced tumor development in a transgenic mouse. 2010/09
• Tumor development in transgenic mice constitutively expressing hypoxia-inducible factor-1? 2010/04
• A novel c-Myc target gene, Mina53, is a favorable prognostic marker in early stage of lung cancer 2010/04
• Mina53, a novel c-Myc target gene, is frequently expressed in lung cancers and exerts oncogenic property in NIH/3T3 cells. 2010
• Expression of Mina53, a novel c-Myc target gene, is a favorable prognostic marker in early stage lung cancer. 2010
• Mutation profile of EGFR gene detected by denaturing high-performance liquid chromatography in Japanese lung cancer patients 2007/01
• Heterogeneous nuclear ribonucleoprotein B1 expression in malignant mesothelioma 2006/12
• Clinico-pathological characteristics of p63 expression in B-cell lymphoma 2006/12
• Hsp90 inhibitors cause G2/M arrest associated with the reduction of Cdc25C and Cdc2 in lung cancer cell lines 2006/12
• Infrequent existence of simian virus 40 large T antigen DNA in malignant mesothelioma in Japan 2006/10
• Reply 2005/12
• hnRNP B1, an early detection marker for lung cancer, decrease DNA repair mediated through inhibition of DNA-dependent protein, kinase activity 2005/10
• Clinical significance of the expression of tumor-associated antigen, RCAS1, and its soluble protein in pleural fluid in malignant mesothelioma 2005/09
• Detection of plasma hnRNP B1 mRNA, a new cancer biomarker, in lung cancer patients by quantitative real-time Polymerase Chain Reaction 2005/04
• Presence of Autoantibody against Heterogeneous Nuclear Ribonucleoprotein B1 in Cerebrospinal Fluid of Patients with Relapsing-Remitting Multiple Sclerosis 2004/12
• Alteration of expression or phosphorylation status of tob, a novel tumor suppressor gene product, is an early event in lung cancer 2003/12
• Detection and discrimination of preneoplastic and early stages of lung adenocarcinoma using hnRNP B1 combined with the cell cycle-related markers p16, cyclin D1, and Ki-67 2003/10
• Lung cacner prevention with (-)-epigallocatechin gallate using monitoring by heterogeneous nuclear ribonucleoprotein B1 2002/10
• Cancer prevention with green tea and monitoring by a new biomarker, hnRNP B1 2001
• Helicobacter Pylori Membrane Protein 1: A new carcinogenic factor of Helicobacter Pylori 2001
• Modulation of gene expression by (-)-epigallocatechin gallate in PC-9 cells using a cDNA expression array 2001
• A new function of green tea: prevention of lifestyle-related diseases. 2001
• hnRNP B1 as early cancer biomarker for occult cancer of human lungs and bronchial dysplasia 2001
• Green tea as a cancer preventive. In “Dietary anticarcinogens and antimutagens, chemical and biological aspects 2000
• Insulin-like growth factor binding protein-6 activates programmed cell death in non-small cell lung cancer cells 2000
• Insulin-like growth factor binding protein-6 inhibits the growth of human bronchial epithelial cells and increases in abuncance with all-trans retinoic acid treatment 2000
• Heterogeneous nuclear ribonucleoprotein B1 expressed in esophageal squamous cell carcinomas as a new biomarker for Diagnosis 2000
• Mechanisms of cancer prevention by tea polyphenols based on inhibition of TNF- expression 2000
• Post-translational mechanisms contribute to the suppression of specific cyclin:CDK complexes by all-trans retinoic acid in human bronchial epithelial cells 1999
• Heterogeneous nuclear ribonucleoprotein B1 as a new marker of early detection for human lung cancers 1999
• Synergistic effects of (--)-epigallocatechin gallate with (--) epicatechin, sulindac, or tamoxifen on caner-preventive activity in the human lung cancer cell line PC-9 1999
• Green tea and cancer chemoprevention 1999
• All-trans retinoic acid inhibits Jun N-terminal kinase by increasing dual-specificity phosphatase activity 1999
• Molecular pathogenesis of interstitial pneumonitis with TNF- transgenic mice 1998
• Anticancer activity of morphine and its synthetic derivative, KT 90, mediated through apoptosis and inhibition of NF-kB activation 1998
• Tumourigenicity of MTG8, a leukemia-related gene, in concert with v-Ha-ras gene in BALB/3T3 cells 1998
• Cancer inhibition by green tea 1998
• Phase I clinical trial with green tea tablets in a Japanese healthy population 1998
• Twist form of teleocidin derivatives is active in in vivo tumor promotion by (-)-bezolactam-V8-310 1998
• Natural inhibitors of carcinogenesis 1998
• Expression of the tumor necrosis factor a gene and early response genes by nodularin, a liver tumor promoter, in primary cultured rat hepatocytes 1997
• Mechanisms of (-)-epigallocatechin gallate (EGCG) and green tea in inhinition of carcinogenesis 1997
• Designing of chimeric DNA/RNA hammerhead ribozymes to be targeted against AML1/MTG8 mRNA 1996
• In vitro catalytic activities of DNA/RMA chimeric hammerhead ribozymes against AML1-MTG8 mRNA, a fused gene transcript in acute myeloid leukemia with t(8;21) 1996
• Japanese green tea as a cancer preventive in humans 1996
• Anti-cancer effects of morphine through inhibition of tumor necrosis factor- release and mRNA expression. 1996
• Significance of marine Toxins in tumor promotion of carcinogenesis. Molecular Approaches to Food Safety Issues Involving Toxic Microorganisms 1996
• Green tea is a cancer preventive in humans 1996
• Expression of early response genes by nodularin, a new liver carcinogen, through inhibition of protein phosphatases 1 and 2A 1996
• Basicstudy of cancer chemopreventive agents 1996
• Basic study of cancer preventions by plant metabolites:(-) Epigallocatechin gallate (EGCG), green tea extract and cryptoporic acid E 1996
• Tumor promotion and prevention of stomach cancer 1995

Books

• Review article Current achievements and future perspectives with liquid biopsy;　2020/10
  ANNOUNCEMENT INFO.;　Personalized Medicine Universe, 9, 3-9
  AUTHOR;　Sueoka-Aragane N
  
• Invited Review Articles Significance of a Liquid Biopsy on Lung Cancer;　2020/04
  ANNOUNCEMENT INFO.;　Haigan, 60, 2, 67 - 73
  AUTHOR;　Aragane Naoko
  
• A new function of green tea: prevention of lifestyle-related diseases.;　2001
  ANNOUNCEMENT INFO.;　In “Healthy Aging for Functional Longevity.” Ed. Park S-C, Hwang E-S, Kim H-S, and Park W-Y, The New York Academy of science, 274-280
  AUTHOR;　Sueoka N, Suganuma M, Sueoka E, Okabe S, Matsuyama S, Imai K, Nakachi K, Fujiki H
  
• Green tea as a cancer preventive. In “Dietary anticarcinogens and antimutagens, chemical and biological aspects;　2000
  ANNOUNCEMENT INFO.;　Ed. Johnson IT and Fenwick GR, Royal society of chemistry, 12-17
  AUTHOR;　Fujiki H., Suganuma M., Okabe S., Sueoka E., Sueoka N., Matsuyama S., Imai K., and Nakachi K
  
• Natural inhibitors of carcinogenesis;　1998
  ANNOUNCEMENT INFO.;　In “Clinical and biological Basis of Lung Cancer Prevention”, 285-290
  AUTHOR;　Fujiki H, Suganuma M, Komori A, Okabe S, Sueoka E, Sueoka N, Kozu T, Tada Y.
  
• Mechanisms of (-)-epigallocatechin gallate (EGCG) and green tea in inhinition of carcinogenesis;　1997
  ANNOUNCEMENT INFO.;　In "International Conference on Food Factors: Chemistry and Cancer Prevention", 127-129
  AUTHOR;　Suganuma M, Okabe S, Oniyama M, Sueoka N, Kozu T, Komori A, Sueoka E, Hara E, Fujiki H
  
• Tumor promotion and prevention of stomach cancer;　1995
  ANNOUNCEMENT INFO.;　In “1st International Gastric Cancer Congress”, 19-26
  AUTHOR;　Fujiki H, Suganuma M, Komori A, Sueoka E, Okabe S, Sueoka N, Aida M, Kozu T, Hamano A, Sakai Y, Tatematsu M
  
• A case of Wegener's granulomatosis with a giant solitary pulmonary mass;　1992
  ANNOUNCEMENT INFO.;　, 30, 909-913
  AUTHOR;　
  

Original Articles

• Response;　2023/06
  ANNOUNCEMENT INFO.;　Chest, 163, 6, e286
  AUTHOR;　Tashiro H, Kuwahara Y, Takahashi K, Sueoka-Aragane N
  
• Absence of copy number gain of EGFR: A possible predictive marker of long-term response to afatinib;　2023/03
  ANNOUNCEMENT INFO.;　Cancer Sci, 114, 3, 1045-1055
  AUTHOR;　Nakamura T, Sato A, Nakashima C, Abe T, Iwanaga K, Umeguchi H, Kawaguchi A, Sueoka-Aragane N
  
• Usefulness of blood biomarkers for predicting venous thromboembolism in Japanese patients with cancer;　2023/03
  ANNOUNCEMENT INFO.;　Oncol Lett, 25, 5, 180
  AUTHOR;　Harada Y, Sato A, Nishioka A, Ogusu S, Matsumoto M, Sueoka E, Kawaguchi A, Kimura S, Sueoka-Aragane N
  
• Anti-cancer effect of afatinib, dual inhibitor of HER2 and EGFR, on novel mutation HER2 E401G in models of patient-derived cancer ;　2023/01
  ANNOUNCEMENT INFO.;　BMC Cancer, 23, 1, 77
  AUTHOR;　Harada Y, Sato A, Nakamura H, Kai K, Kitamura S, Nakamura T, Kurihara Y, Ikeda S, Sueoka E, Kimura S, Sueoka-Aragane N
  
• Effect of Azithromycin on Exacerbations in Asthma Patients with Obesity: Protocol for a Multi-Center, Prospective, Single-Arm Intervention Study ;　2023/01
  ANNOUNCEMENT INFO.;　Int J Environ Res Public Health, 20, 3, 1861
  AUTHOR;　Tashiro H, Takahashi K, Uchida M, Kurihara Y, Sadamatsu H, Takamori A, Kimura S, Sueoka-Aragane N
  
• Factors related to the diagnosis of lung cancer by transbronchial biopsy with endobronchial ultrasonography and a guide sheath;　2022/12
  ANNOUNCEMENT INFO.;　Thorac Cancer, 13, 24, 3459-3466
  AUTHOR;　Kurihara Y, Tashiro H, Takahashi K, Tajiri R, Kuwahara Y, Kajiwara K, Komiya N, Ogusu S, Nakashima C, Nakamura T, Kimura S, Sueoka-Aragane N
  
• Obesity affects pulmonary function in Japanese adult patients with asthma, but not those without asthma;　2022/09
  ANNOUNCEMENT INFO.;　Sci Rep, 12, 1, 16457
  AUTHOR;　Hiroki Tashiro, Koichiro Takahashi, Yuki Kurihara, Hironori Sadamatsu, Yuki Kuwahara, Ryo Tajiri, Shinya Kimura, Naoko Sueoka-Aragane
  
• Real-World Data Analysis of Pembrolizumab Monotherapy for NSCLC Using Japanese Postmarketing All-Case Surveillance Data;　2022/09
  ANNOUNCEMENT INFO.;　JTO Clin Res Rep, 3, 11, 100404
  AUTHOR;　*Terai H, Soejima K, Shimokawa A, Horinouchi H, Shimizu J, Hase T, Kanemaru R, Watanabe K, Ninomiya K, Aragane N, Yanagitani N, Sakata Y, Seike M, Fujimoto D, Kasajima M, Kubo A, Kusumoto S, Oyamada Y, Fujiwara K, Mori M, Hashimoto M, Shingyoji M, Kodani M, Sakamoto J, Agatsuma T, Kashiwabara K, Inomata M, Tachihara M, Tanaka K, Hayashihara K, Koyama N, Matsui K, Minato K, Jingu D, Sakashita H, Hara S, Naito T, Okada A, Tanahashi M, Sato Y, Asano K, Takeda T, Nakazawa K, Harada T, Shibata K, Kato T, Miyaoka E, Yoshino I, Gemma A, Mitsudomi T
  
• Clinical utility of comprehensive genomic profiling in Japan: Result of PROFILE-F study ;　2022/03
  ANNOUNCEMENT INFO.;　PLoS One, 17, 3, e0266112
  AUTHOR;　*Aoyagi Y, Kano Y, Tohyama K, Matsudera S, Kumaki Y, Takahashi K, Mitsumura T, Harada Y, Sato A, Nakamura H, Sueoka E, Aragane N, Kimura K, Onishi I, Takemoto A, Akahoshi K, Ono H, Ishikawa T, Tokunaga M, Nakagawa T, Oshima N, Nakamura R, Takagi M, Asakage T, Uetake H, Tanabe M, Miyake S, Kinugasa Y, Ikeda S
  
• Anti-IL-5 Agents for the Treatment of Idiopathic Chronic Eosinophilic Pneumonia: A Case Series;　2022/02
  ANNOUNCEMENT INFO.;　J Asthma Allergy, 15, 169-177
  AUTHOR;　Tashiro H, Takahashi K, Kurihara Y, Sadamatsu H, Kuwahara Y, Kimura S, Sueoka-Aragane N
  
• Integrated approach to functional analysis of an ERBB2 variant of unknown significance detected by a cancer gene panel test ;　2022/02
  ANNOUNCEMENT INFO.;　Cell Oncol (Dordr), 45, 1, 121-134
  AUTHOR;　Harada Y, Sato A, Araki M, Matsumoto S, Isaka Y, Sagae Y, Abe T, Aoyagi Y, Sueoka E, Okuno Y, Kimura S, Sueoka-Aragane N
  
• Factors Associated with Reduction of Sedentary Time Following Tiotropium/Olodaterol Therapy in Treatment-Naïve Chronic Obstructive Pulmonary Disease;　2021/12
  ANNOUNCEMENT INFO.;　Int J Chron Obstruct Pulmon Dis, 16, 3297-3307
  AUTHOR;　Koichiro Takahashi, Hiroki Tashiro, Ryo Tajiri, Ayako Takamori, Masaru Uchida, Go Kato, Yuki Kurihara, Hironori Sadamatsu, Takashi Kinoshita, Makoto Yoshida, Atsushi Kawaguchi, Shinya Kimura, Naoko Sueoka-Aragane, Tomotaka Kawayama, Saga-naïve COPD Physical Activity Evaluation (SCOPE) Study Investigator Group
  
• Severity of constipation related to palonosetron during first-line chemotherapy: a retrospective observational study ;　2021/08
  ANNOUNCEMENT INFO.;　Support Care Cancer, 29, 8, 4723-4732
  AUTHOR;　○Sakiko Kimura, Kazuhisa Hosoya, Kenji Ogata, Tatsuya Furuno, Rintaro Sogawa, Koji Takeuchi, Masanobu Tasaki, Atsushi Kawaguchi, Atsujiro Nishioka, Naoko Sueoka-Aragane, Hirokazu Noshiro, Yuichiro Kuratomi, Masatoshi Yokoyama, Mitsuru Noguchi, Keizo Anzai, Yoshio Yamashita, Shinya Kimura, Hiroyuki Irie
  
• Skeletal muscle is associated with exercise tolerance evaluated by cardiopulmonary exercise testing in Japanese patients with chronic obstructive pulmonary disease ;　2021/08
  ANNOUNCEMENT INFO.;　Sci Rep, 11, 1, 15862
  AUTHOR;　Hiroki Tashiro, Koichiro Takahashi, Masahide Tanaka, Hironori Sadamatsu, Yuki Kurihara, Ryo Tajiri, Ayako Takamori, Hiroyuki Naotsuka, Hiroki Imaizumi, Shinya Kimura, Naoko Sueoka-Aragane
  
• The role of comprehensive analysis with circulating tumor DNA in advanced non-small cell lung cancer patients considered for osimertinib treatment ;　2021/06
  ANNOUNCEMENT INFO.;　Cancer Med, 10, 12, 3873-3885
  AUTHOR;　Naoko Sueoka-Aragane, Chiho Nakashima, Hironori Yoshida, Naohisa Matsumoto, Kentaro Iwanaga, Noriyuki Ebi, Akihiro Nishiyama, Kazuhiro Yatera, Shoichi Kuyama, Minoru Fukuda, Sunao Ushijima, Hitomi Umeguchi, Daijiro Harada, Kosuke Kashiwabara, Takayuki Suetsugu, Nobukazu Fujimoto, Fumihiro Tanaka, Hidetaka Uramoto, Chiharu Yoshii, Katsumi Nakatomi, Genju Koh, Nobuhiko Seki, Keisuke Aoe, Kaname Nosaki, Koji Inoue, Ayako Takamori, Atsushi Kawaguchi
  
• Effect of health locus of control on physical activity in stable patients with chronic obstructive pulmonary diseases ;　2021/06
  ANNOUNCEMENT INFO.;　J Phys Ther Sci, 33, 6, 480-488
  AUTHOR;　Shojiro Egoshi, Shinichiro Hayashi, Jun Horie, Shuichi Shiranita, Hisashi Watanabe, Futoshi Kawaura, Koichiro Takahashi, Toyoko Asami, Naoko Sueoka-Aragane
  
• ALDH2 polymorphism rs671 is a predictor of PD-1/PD-L1 inhibitor efficacy against thoracic malignancies ;　2021/05
  ANNOUNCEMENT INFO.;　BMC Cancer, 21, 1, 584
  AUTHOR;　○Akiko Matsumoto, Chiho Nakashima, Shinya Kimura, Eizaburo Sueoka, Naoko Aragane
  
• IMpower132: Atezolizumab plus platinum-based chemotherapy vs chemotherapy for advanced NSCLC in Japanese patients ;　2021/04
  ANNOUNCEMENT INFO.;　Cancer Sci, 112, 4, 1534-1544
  AUTHOR;　*Makoto Nishio, Haruhiro Saito, Koichi Goto, Satoshi Watanabe, Naoko Sueoka-Aragane, Yusuke Okuma, Kazuo Kasahara, Kenichi Chikamori, Yuki Nakagawa, Tomohisa Kawakami
  
• A Low Body Mass Index Is Associated with Unsuccessful Treatment in Patients with Mycobacterium avium Complex Pulmonary Disease ;　2021/04
  ANNOUNCEMENT INFO.;　J Clin Med, 10, 8, 1576
  AUTHOR;　Hironori Sadamatsu, Koichiro Takahashi, Hiroki Tashiro, Koji Kusaba, Tetsuro Haraguchi, Yuki Kurihara, Natsuko Komiya, Chiho Nakashima, Tomomi Nakamura, Shinya Kimura, Naoko Sueoka-Aragane
  
• Evaluation of olfactory dysfunction to estimate the presence of eosinophilic chronic rhinosinusitis in patients with asthma;　2021/01
  ANNOUNCEMENT INFO.;　Respir Investig, 59, 1, 126-134
  AUTHOR;　Koichiro Takahashi, Hironori Sadamatsu, Kumiko Suzuki, Hiroki Tashiro, Shinya Kimura, Yuichiro Kuratomi, Naoko Sueoka-Aragane
  
• Clinical features of Japanese patients with exacerbations of chronic obstructive pulmonary disease;　2020/12
  ANNOUNCEMENT INFO.;　BMC Pulm Med , 20, 1, 318
  AUTHOR;　Hiroki Tashiro, Yuki Kurihara, Koichiro Takahashi, Hironori Sadamatsu, Tetsuro Haraguchi, Ryo Tajiri, Ayako Takamori, Shinya Kimura, Naoko Sueoka-Aragane
  
• Multiplex gene-panel testing for lung cancer patients;　2020/12
  ANNOUNCEMENT INFO.;　Pathol Int, 70, 12, 921-931
  AUTHOR;　*Yasushi Yatabe, Kuniko Sunami, Koichi Goto, Kazuto Nishio, Naoko Aragane, Sadakatsu Ikeda, Akira Inoue, Ichiro Kinoshita, Hideharu Kimura, Tomohiro Sakamoto, Miyako Satouchi, Junichi Shimizu, Koji Tsuta, Shinichi Toyooka, Kazumi Nishino, Yutaka Hatanaka, Shingo Matsumoto, Masashi Mikubo, Tomoyuki Yokose, Hirotoshi Dosaka-Akita
  
• Biomarkers for Overweight in Adult-Onset Asthma;　2020/10
  ANNOUNCEMENT INFO.;　J Asthma Allergy, 13, 409-414
  AUTHOR;　Hiroki Tashiro, Koichiro Takahashi, Hironori Sadamatsu, Yuki Kurihara, Tetsuro Haraguchi, Ryo Tajiri, Ayako Takamori, Shinya Kimura, Naoko Sueoka-Aragane
  
• First-Line Treatment with Tiotropium/Olodaterol Improves Physical Activity in Patients with Treatment-Naïve Chronic Obstructive Pulmonary Disease;　2020/09
  ANNOUNCEMENT INFO.;　Int J Chron Obstruct Pulmon Dis, 15, 2115-2126
  AUTHOR;　Koichiro Takahashi, Masaru Uchida, Go Kato, Ayako Takamori, Takashi Kinoshita, Makoto Yoshida, Ryo Tajiri, Keisuke Kojima, Hiroshi Inoue, Hiromi Kobayashi, Hironori Sadamatsu, Hiroki Tashiro, Masahide Tanaka, Shinichiro Hayashi, Atsushi Kawaguchi, Shinya Kimura, Naoko Sueoka-Aragane, Tomotaka Kawayama, Saga-naïve COPD Physical Activity Evaluation (SCOPE) Study Investigator Group
  
• A phase 2 basket trial of combination therapy with trastuzumab and pertuzumab in patients with solid cancers harboring human epidermal growth factor receptor 2 amplification (JUPITER trial);　2020/08
  ANNOUNCEMENT INFO.;　Medicine (Baltimore), 99, 32, e21457
  AUTHOR;　*Kenta Takahashi, Eri Ishibashi, Toshio Kubo, Yohei Harada, Hideyuki Hayashi, Masayuki Kano, Yasushi Shimizu, Hidekazu Shirota, Yukiko Mori, Manabu Muto, Chikashi Ishioka, Hirotoshi Dosaka-Akita, Hisahiro Matsubara, Hiroshi Nishihara, Naoko Sueoka-Aragane, Shinichi Toyooka, Akihiro Hirakawa, Ukihide Tateishi, Satoshi Miyake, Sadakatsu Ikeda
  
• Targeting aberrant DNA hypermethylation as a driver of ATL leukemogenesis using the new oral demethylating agent OR-2100;　2020/08
  ANNOUNCEMENT INFO.;　Blood, 136, 7, 871-884
  AUTHOR;　○Tatsuro Watanabe, Satoshi Yamashita, Hiroshi Ureshino, Kazuharu Kamachi, Yuki Kurahashi, Yuki Fukuda-Kurahashi, Nao Yoshida, Naoko Hattori, Hideaki Nakamura, Akemi Sato, Atsushi Kawaguchi, Naoko Sueoka-Aragane, Kensuke Kojima, Seiji Okada, Toshikazu Ushijima, Shinya Kimura, Eisaburo Sueoka
  
• Origin of circulating free DNA in patients with lung cancer;　2020/07
  ANNOUNCEMENT INFO.;　PLoS One, 15, 7, e0235611
  AUTHOR;　Tomonori Abe, Chiho Nakashima, Akemi Sato, Yohei Harada, Eisaburo Sueoka, Shinya Kimura, Atsushi Kawaguchi, Naoko Sueoka-Aragane
  
• Clinical impact of advanced chronic kidney disease in patients with non-HIV pulmonary cryptococcosis;　2020/04
  ANNOUNCEMENT INFO.;　BMC Pulm Med, 20, 1, 116
  AUTHOR;　Hiroki Tashiro, Tetsuro Haraguchi, Koichiro Takahashi, Hironori Sadamatsu, Ryo Tajiri, Ayako Takamori, Shinya Kimura, Naoko Sueoka-Aragane
  
• The non-antibiotic macrolide EM900 attenuates HDM and poly(I:C)-induced airway inflammation with inhibition of macrophages in a mouse model;　2020/01
  ANNOUNCEMENT INFO.;　Inflamm Res. , 69, 1, 139-151
  AUTHOR;　Sadamatsu H, Takahashi K, Tashiro H, Kato G, Noguchi Y, Kurata K, Ōmura S, Kimura S, Sunazuka T, Sueoka-Aragane N
  
• The Nonantibiotic Macrolide EM900 Attenuates House Dust Mite-Induced Airway Inflammation in a Mouse Model of Obesity-Associated Asthma;　2020
  ANNOUNCEMENT INFO.;　Int Arch Allergy Immunol, 181, 9, 665-674
  AUTHOR;　Hironori Sadamatsu, Koichiro Takahashi, Hiroki Tashiro, Yuki Kurihara, Go Kato, Masaru Uchida, Yoshihiko Noguchi, Keigo Kurata, Satoshi Ōmura, Toshiaki Sunazuka, Shinya Kimura, Naoko Sueoka-Aragane
  
• Association of Genetic Polymorphisms With Afatinib-induced Diarrhoea;　2020
  ANNOUNCEMENT INFO.;　In Vivo, 34, 3, 1415-1419
  AUTHOR;　Rintaro Sogawa, Chiho Nakashima, Tomomi Nakamura, Koji Takeuchi, Sakiko Kimura, Kazutoshi Komiya, Yutaka Narisawa, Shinya Kimura, Naoko Sueoka-Aragane
  
• Discontinuation due to immune-related adverse events is a possible predictive factor for immune checkpoint inhibitors in patients with non-small cell lung cancer.;　2019/09
  ANNOUNCEMENT INFO.;　Thorac Cancer. , 10, 9, 1798-1804
  AUTHOR;　Komiya K, Nakamura T, Abe T, Ogusu S, Nakashima C, Takahashi K, Kimura S, Sueoka-Aragane N
  
• Identification of the BRAF V600E mutation in Japanese patients with hairy cell leukemia and related diseases using a quenching probe method. ;　2018
  ANNOUNCEMENT INFO.;　Int J Hematol. , 108, 4, 416-422
  AUTHOR;　*Itamura H, Ide M, Sato A, Sueoka-Aragane N, Sueoka E, Nishida A, Masunari T, Aoki S, Takizawa J, Suzumiya J, Kimura S
  
• Current Status and Problems of T790M Detection, a Molecular Biomarker of Acquired Resistance to EGFR Tyrosine Kinase Inhibitors, with Liquid Biopsy and Re-biopsy.;　2018
  ANNOUNCEMENT INFO.;　Anticancer Res. , 38, 6, 3559-3566
  AUTHOR;　Komiya K, Nakashima C, Nakamura T, Hirakawa H, Abe T, Ogusu S, Takahashi K, Takeda Y, Egashira Y, Kimura S, Sueoka-Aragane N
  
• Mechanisms of acquired resistance to afatinib clarified with liquid biopsy;　2018
  ANNOUNCEMENT INFO.;　PLoS One. , 13, 12, e0209384
  AUTHOR;　Nakamura T, Nakashima C, Komiya K, Kitera K, Hirai M, Kimura S, Sueoka-Aragane N
  
• Automated DNA extraction using cellulose magnetic beads can improve EGFR point mutation detection with liquid biopsy by efficiently recovering short and long DNA fragments.;　2018
  ANNOUNCEMENT INFO.;　Oncotarget. , 9, 38, 25181?25192
  AUTHOR;　Nakashima C, Sato A, Abe T, Kato J, Hirai M, Nakamura T, Komiya K, Sueoka E, Kimura S, Sueoka-Aragane N.
  
• Anxiety and depression associated with tyrosine kinase inhibitor discontinuation in patients with chronic myeloid leukemia;　2018
  ANNOUNCEMENT INFO.;　Int J Clin Oncol. , 23, 5, 974-979
  AUTHOR;　Sogawa R, Kimura S, Yakabe R, Mizokami Y, Tasaki M, Sueoka-Aragane N, Narisawa Y, Kimura S.
  
• Investigation of Appropriate Pre-analytical Procedure for Circulating Free DNA from Liquid Biopsy.;　2018
  ANNOUNCEMENT INFO.;　Oncotarget. , 9, 61, 31904-31914
  AUTHOR;　○Sato A, Nakashima C, Abe T, Kato J, Hiai M, Nakamura T, Komiya K, Kimura S, Sueoka E, Sueoka-Aragane N.
  
• Relationship between the duration of trimethoprim/sulfamethoxazole treatment and the clinical outcome of pulmonary nocardiosis.;　2018
  ANNOUNCEMENT INFO.;　Respir Investig. , 56, 2, 166-172
  AUTHOR;　*Tashiro H, Takahashi K, Kusaba K, Tanaka M, Komiya K, Nakamura T, Aoki Y, Kimura S, Sueoka-Aragane N
  
• Phase II trial of gefitinib plus pemetrexed after relapse using first-line gefitinib in patients with non-small cell lung cancer harboring EGFR gene mutations.;　2018
  ANNOUNCEMENT INFO.;　Lung Cancer. , 124, 65-70
  AUTHOR;　*Uchibori K, Satouchi M, Sueoka-Aragane N, Urata Y, Sato A, Imamura F, Inoue T, Tachihara M, Kobayashi K, Katakami N, Kokan C, Hirashima T, Iwanaga K, Mori M, Aoe K, Morita S, Negoro S.
  
• Chemotherapy for primary mediastinal yolk sac tumor in a patient undergoing chronic hemodialysis: a case report.;　2017
  ANNOUNCEMENT INFO.;　J Med Case Rep. , 11, 1, 43
  AUTHOR;　Hirakawa H, Nakashima C, Nakamura T, Masuda M, Funakoshi T, Nakagawa S, Horimatsu T, Matsubara K, Muto M, Kimura S, Sueoka-Aragane N
  
• Functional analysis of Discoidin domain receptor 2 mutation and expression in squamous cell lung cancer.;　2017
  ANNOUNCEMENT INFO.;　Lung Cancer. , 110, 35-41
  AUTHOR;　Kobayashi-Watanabe N, Sato A, Watanabe T, Abe T, Nakashima C, Sueoka E, Kimura S, Sueoka-Aragane N.
  
• Severity and predictive factors of adverse events in pemetrexed-containing chemotherapy for non-small cell lung cancer.;　2017
  ANNOUNCEMENT INFO.;　Med Oncol. , 34, 12, 195
  AUTHOR;　＊Miyahara T, Sueoka-Aragane N, Iwanaga K, Ureshino N, Komiya K, Nakamura T, Nakashima C, Abe T, Matsunaga H, Kimura S.
  
• Plasma T790M and HGF as potential predictive markers for EGFR-TKI re-challenge.;　2017
  ANNOUNCEMENT INFO.;　Oncol Lett. , 13, 6, 4939-4946
  AUTHOR;　Nakamura T, Watanabe N, Sato A, Komiya K, Umeguchi H, Hosomi T, Hirai M, Sueoka E, Kimura S, Sueoka-Aragane N
  
• Thin-section CT findings of multicentric Castleman disease changing over 10 years.;　2017
  ANNOUNCEMENT INFO.;　J Thorac Imaging. , 32, 6, W81-W83
  AUTHOR;　Tashiro H, Egashira R, Takahashi K, Fukui S, Kimura S, Nakazono T, Nojiri J, Fukuoka J, Irie H, Sueoka-Aragane N.
  
• Pre-existing chronic interstitial pneumonia is poor prognostic factor of Goodpasture's syndrome: a case and review of the literature;　2017
  ANNOUNCEMENT INFO.;　J Med Case Rep. , 11, 1, 102
  AUTHOR;　Tashiro H, Takahashi K, Ikeda Y, Uchiumi S, Fukuda M, Miyazono M, Kimura S, Sueoka-Aragane N.
  
• Saturated Fatty Acid Increases Lung Macrophages and Augments House Dust Mite-Induced Airway Inflammation in Mice Fed with High-Fat Diet.;　2017
  ANNOUNCEMENT INFO.;　Inflammation. , 40, 3, 1072-1086
  AUTHOR;　Tashiro H, Takahashi K, Sadamatsu H, Kato G, Kurata K, Kimura S, Sueoka-Aragane N.
  
• Successful treatment of pulmonary nocardiosis with Fluoroquinolone in bronchial asthma and bronchiectasis;　2017
  ANNOUNCEMENT INFO.;　Respirol Case Rep., 5, 3, e00229
  AUTHOR;　Sadamatsu H, Takahashi K, Tashiro H, Komiya K, Nakamura T, Sueoka-Aragane N
  
• Characteristics and prognosis of microscopic polyangiitis with bronchiectasis, Journal of Thoracic Disease;　2017
  ANNOUNCEMENT INFO.;　J Thorac Dis., 9, 2, 303-309
  AUTHOR;　Tashiro H, Takahashi K, Tanaka M, Komiya K, Nakamura T, Kimura S, Tada Y, Sueoka-Aragane N
  
• Mutation profile of B-raf gene analyzed by fully automated system and clinical features in Japanese melanoma patients;　2017
  ANNOUNCEMENT INFO.;　Pathol Oncol Res., 23, 1, 181-188
  AUTHOR;　Ide M, Koba K, Sueoka-Aragane N, Sato A, Nagano Y, Inoue T, Misago N, Narisawa Y, Kimura S, Sueoka E
  
• Detection of KRAS Mutations in plasma DNA using a fully automated rapid detection system in colorectal cancer patients;　2017
  ANNOUNCEMENT INFO.;　Pathol Oncol Res.
  AUTHOR;　Hosoya K, Matsusaka S, Kashiwada T, Suzuki K, Ureshino N, Sato A, Miki Y, Kitera K, Hirai M, Hatake K, Kimura S, Sueoka-Aragane N
  
• Interleukin-33 from monocytes recruited to the lung contributes to house dust mite-induced airway inflammation in a mouse model.;　2016
  ANNOUNCEMENT INFO.;　PLoS One., 11, 6, e0157571
  AUTHOR;　Tashiro H, Takahashi K, Hayashi S, Kato G, Kurata K, Kimura S, Sueoka-Aragane N.
  
• Monitoring EGFR T790M with plasma DNA from lung cancer patients in a prospective observational study.;　2016
  ANNOUNCEMENT INFO.;　Cancer Sci., 107, 2, 162-7
  AUTHOR;　Sueoka-Aragane N, Katakami N, Miyako M, Yokota S, Aoe K, Iwanaga K, Otsuka K, Morita S, Kimura S, Negoro S.
  
• Phase II trial of weekly nab-paclitaxel for previously treated advancednon–small cell lung cancer: Kumamoto thoracic oncology study group(KTOSG) trial 1301;　2016
  ANNOUNCEMENT INFO.;　Lung Cancer., 99, 41-5
  AUTHOR;　Sakata S, Saeki S, Okamoto I, Otsubo K, Komiya K, Morinaga R, Yoneshima Y, Koga Y, Enokizu A, Kishi H, Hirosako S, Yamaguchi E, Aragane N, Fujii S, Harada T, Iwama E, Semba H, Nakanishi Y, Kohrogi H
  
• SPARC is a Possible Predictive Marker for Albumin-bound Paclitaxel in Non-small Cell Lung Cancer.;　2016
  ANNOUNCEMENT INFO.;　Onco Targets Ther., 9, 6663-6668
  AUTHOR;　Komiya K, Nakamura T, Sadamatsu H, Nakashima C, Takahashi K, Umeguchi H, Watanabe N, Sato A, Takeda Y, Kimura S, Sueoka-Aragane N
  
• Torin2 potentiates anti-cancer effects for adult T-cell leukemia/lymphoma by inhibiting mammalian target of rapamycin.;　2016
  ANNOUNCEMENT INFO.;　Anticancer Res., https://www.ncbi.nlm.nih.gov/labs/articles/26722032/, 36, 1, 95-102
  AUTHOR;　Watanabe T, Sato A, Kobayashi-Watanabe N, Sueoka-Aragane N, Kimura S, Sueoka E
  
• Evaluation of a cloud-based local-read paradigm for imaging evaluations in oncology clinical trials for lung cancer.;　2015
  ANNOUNCEMENT INFO.;　Acta Radiol Open., 4, 12, 2058460115588103
  AUTHOR;　Sueoka-Aragane N, Kobayashi N, Bonnard E, Charbonnier C, Yamamichi J, Mizobe H, Kimura S
  
• 2-Hydroxypropyl-β-cyclodextrin Acts as a Novel Anticancer Agent.;　2015
  ANNOUNCEMENT INFO.;　LoS One., 10, 11, e0141946.
  AUTHOR;　Yokoo M, Kubota Y, Motoyama K, Higashi T, Taniyoshi M, Tokumaru H, Nishiyama R, Tabe Y, Mochinaga S, Sato A, Sueoka-Aragane N, Sueoka E, Arima H, Irie T, Kimura S
  
• Failure mode and effects analysis of medication adherence in patients with chronic myeloid leukemia.;　2015
  ANNOUNCEMENT INFO.;　Int J Clin Oncol., 20, 6, 1203-10
  AUTHOR;　Hosoya K, Mochinaga S, Emoto A, Yokoo H, Tokushima H, Egoshi M, Sueoka-Aragane N, Kimura S
  
• Volume-based response evaluations with consensual lesion selection using cloud solutions (SaaS) in clinical trials: a pilot study;　2015
  ANNOUNCEMENT INFO.;　Acad Radiol., 22, 2, 217-25
  AUTHOR;　Oubel E, Bonnard E, Sueoka-Aragane N, Kobayashi N, Charbonnier C, Yamamichi J, Mizobe H, Kimura S
  
• For Hanshin-Saga Collaborative Cancer Study Group. Monitoring EGFR T790M with plasma DNA from lung cancer patients in a prospective observational study.;　2015
  ANNOUNCEMENT INFO.;　Cancer Sci., 107, 2, 162-7
  AUTHOR;　Sueoka-Aragane N, Katakami N, Satouchi M, Yokota S, Aoe K, Iwanaga K, Otsuka K, Morita S, Kimura S, Negoro S
  
• Usefulness of plasma HGF level for monitoring acquired resistance to EGFR tyrosine kinase inhibitors in non-small cell lung cancer;　2015
  ANNOUNCEMENT INFO.;　Oncol Rep., 33, 1, 391-6
  AUTHOR;　Umeguchi H, Sueoka-Aragane N, Kobayashi N, Nakamura T, Sato A, Takeda Y, Hayashi S, Sueoka E, Kimura S.
  
• Correlation between plasma DNA and tumor status in an animal model. ;　2014
  ANNOUNCEMENT INFO.;　PLoS One., 9, 12, e111881
  AUTHOR;　Sueoka-Aragane N, Sato A, Kobayashi N, Ide M, Yokoo M, Nagano Y, Sueoka E, Kimura S
  
• NK314 potentiates anti-tumor activity with adult T-cell leukemia-lymphoma cells by inhibition of dual targets on topoisomerase IIα and DNA-dependent protein kinase.;　2011
  ANNOUNCEMENT INFO.;　Blood　, 117, 13, 3575-3584
  AUTHOR;　Hisatomi T, Sueoka-Aragane N, Sato A, Tomimasu R, Ide M, Kurimasa A, Okamoto K, Kimura S, Sueoka E
  
• Phase II study of gefitinib as a first-line therapy in elderly patients with pulmonary adenocarcinoma: West Japan Thoracic Oncology Group Study 0402.;　2011
  ANNOUNCEMENT INFO.;　Jpn J Clin Oncol.　, 41, 8, 948-952
  AUTHOR;　Kobayashi M, Matsui K, Katakami N, Takeda K, Moriyama A, Iwamoto Y, Takada M, Yoshioka H, Sueoka-Aragane N, Nakagawa K
  
• A non-invasive system for monitoring resistance to EGFR tyrosine kinase inhibitors with plasma DNA.;　2011
  ANNOUNCEMENT INFO.;　J Thorac Oncol　, 6, 10, 1639-1648
  AUTHOR;　Nakamura T, Sueoka-Aragane N, Iwanaga K, Sato A, Komiya K, Abe T, Ureshino N, Hayashi S, Hosomi T, Hirai M, Sueoka E, Kimura S
  
• A Fully Integrated and Automated Detection System for Single Nucleotide Polymorphisms of UGT1A1 and CYP2C19.;　2011
  ANNOUNCEMENT INFO.;　Oncol Res　, 19, 3-4, 111-114
  AUTHOR;　Ureshino N, Aragane N, Nakamura T, Ide M, Mochinaga S, Fukushima N, Hayashi S, Sueoka E, Kimura S
  
• A fully integrated, automated and rapid detection system for KRAS mutations.;　2011
  ANNOUNCEMENT INFO.;　Oncol Rep　, 26, 3, 609-613
  AUTHOR;　Ureshino N, Sueoka-Aragane N, Nakamura T, Sato A, Komiya K, Iwanaga K, Mitsuoka M, Takeda Y, Hayashi S, Sueoka E, Kimura S
  
• Mina53, a novel c-Myc target gene, is frequently expressed in lung cancers and exerts oncogenic property in NIH/3T3 cells.;　2010
  ANNOUNCEMENT INFO.;　J Cancer Res Clin Oncol.　, 136, 3, 465-473
  AUTHOR;　Komiya K, Sueoka-Aragane N, Sato A, Hisatomi T, Sakuragi T, Mitsuoka M, Sato T, Hayashi S, Izumi H, Tsuneoka M, Sueoka E.
  
• Expression of Mina53, a novel c-Myc target gene, is a favorable prognostic marker in early stage lung cancer.;　2010
  ANNOUNCEMENT INFO.;　Lung Cancer　, 69, 2, 232-238
  AUTHOR;　Komiya K, Sueoka-Aragane N, Sato A, Hisatomi T, Sakuragi T, Mitsuoka M, Sato T, Hayashi S, Izumi H, Tsuneoka M, Sueoka E.
  
• Mina53, a novel c-Myc target gene, is frequently expressed in lung cancers and exerts oncogenic property in NIH/3T3 cells.;　2009
  ANNOUNCEMENT INFO.;　J Cancer Res Clin Oncol. Epub 2009 Sep 16.
  AUTHOR;　Komiya K, Sueoka-Aragane N, Sato A, Hisatomi T, Sakuragi T, Mitsuoka M, Sato T, Hayashi S, Izumi H, Tsuneoka M, Sueoka E.
  
• Expression of Mina53, a novel c-Myc target gene, is a favorable prognostic marker in early stage lung cancer.;　2009
  ANNOUNCEMENT INFO.;　Lung Cancer. 2009 Nov 13. [Epub]
  AUTHOR;　Komiya K, Sueoka-Aragane N, Sato A, Hisatomi T, Sakuragi T, Mitsuoka M, Sato T, Hayashi S, Izumi H, Tsuneoka M, Sueoka E.
  
• Exon 19 of EGFR mutation in relation to the CA-repeat polymorphism in intron 1;　2008
  ANNOUNCEMENT INFO.;　Cancer Sci, 99, 1180-1187
  AUTHOR;　Sueoka-Aragane N, Imai K, Komiya K, Sato A, Tomimasu R, Hisatomi T, Sakuragi T, Mitsuoka M, Hayashi S, Nakachi K, Sueoka E
  
• Establishment of a new method, transcription-reverse transcription concerted reaction, for detection of plasma hnRNP B1 mRNA, a biomarker of lung cancer;　2008
  ANNOUNCEMENT INFO.;　J. Cancer Res. Clin. Oncol, 134, 1191-1197
  AUTHOR;　Sato A, Sueoka-Aragane N, Saitoh J, Komiya K, Hisatomi T, Tomimasu R, Hayashi S, Sueoka E
  
• Disseminated infection by Bipolaris spicifera in an immunocompetent subject;　2008
  ANNOUNCEMENT INFO.;　Med Mycol., 46, 361-365
  AUTHOR;　Kobayashi H, Sano A, Aragane N, Fukuoka M, Tanaka M, Kawaura F, Fukuno Y, Matsuishi E, Hayashi S.
  
• Significantly increased antibody response to heterogeneous nuclear ribonucleoproteins in cerebrospinal fluid of multiple sclerosis patients but not in patients with human T-lymphotropic virus type I-associated myelopathy/tropical spastic paraparesis;　2008
  ANNOUNCEMENT INFO.;　J Neurovirol, 14, 130-135
  AUTHOR;　Yukitake M, Sueoka E, Sueoka-Aragane N, Sato A, Ohashi H, Yakushiji Y, Saito M, Osame M, Izumo S, Kuroda Y.
  
• High-resolution computed tomography characterization of interstitial lung diseases in polymyositis/dermatomyositis;　2008
  ANNOUNCEMENT INFO.;　J Rheumatol, 35, 260-269
  AUTHOR;　Hayashi S, Tanaka M, Kobayashi H, Nakazono T, Satoh T, Fukuno Y, Aragane N, Tada Y, Koarada S, Ohta A, Nagasawa K.
  
• Mutation profile of EGFR gene detected by denaturing high-performance liquid chromatography in Japanese lung cancer patients;　2007/01
  ANNOUNCEMENT INFO.;　J. Cancer Res. Clin. Oncol., 133, 93-102
  AUTHOR;　Sueoka N, Sato A, Eguchi H, Komiya K, Sakuragi T, Mitsuoka M, Satoh T, Hayashi S, Nakachi K, Sueoka E
  
• Heterogeneous nuclear ribonucleoprotein B1 expression in malignant mesothelioma;　2006/12
  ANNOUNCEMENT INFO.;　Cancer Sci, 97, 1175-81
  AUTHOR;　Hiraki A, Murakami T, Aoe K, Sueoka E, Sueoka N, Taguchi K, Kamei T, Sugi K, Ueoka H, Kishimoto T
  
• Clinico-pathological characteristics of p63 expression in B-cell lymphoma;　2006/12
  ANNOUNCEMENT INFO.;　 Cancer Sci., 97, 1050-5
  AUTHOR;　Fukushima N, Satoh Y, Sueoka N, Sato A, Ide M, Hisatomi T, Kuwahara N, Tomimasu, R, Tsuneyoshi N, Funai N, Sano M, Tokunaga O, Sueoka E.
  
• Hsp90 inhibitors cause G2/M arrest associated with the reduction of Cdc25C and Cdc2 in lung cancer cell lines;　2006/12
  ANNOUNCEMENT INFO.;　J. Cancer Res. Clin. Oncol., 132, 150-8
  AUTHOR;　Senju M, Sueoka N, Sato A, Iwanaga K, Sakao Y, Tomimitsu S, Tominaga M, Irie K, Hayashi S, Sueoka E
  
• Pulmonary infarction as the initial manifestation of Takayasu's arteritis;　2006/11
  ANNOUNCEMENT INFO.;　Intern. Med., 45, 725-8
  AUTHOR;　Nakamura T, Hayashi S, Fukuoka M, Sueoka N, Nagasawa K
  
• Infrequent existence of simian virus 40 large T antigen DNA in malignant mesothelioma in Japan;　2006/10
  ANNOUNCEMENT INFO.;　Cancer Sci., 97, 292-5
  AUTHOR;　Aoe K, Hiraki A, Murakami T, Toyooka S, Shivapurkar N, Gazdar AF, Sueoka N, Taguchi K, Kamei T, Takeyama H, Sugi K, Kishimoto T
  
• Reply;　2005/12
  ANNOUNCEMENT INFO.;　Ann Neurol., 57, 931-932
  AUTHOR;　Sueoka E, Sueoka N, Sato A, Kuroda Y
  
• hnRNP B1, an early detection marker for lung cancer, decrease DNA repair mediated through inhibition of DNA-dependent protein, kinase activity;　2005/10
  ANNOUNCEMENT INFO.;　Biochem. Biophysic. Res. Comm., 333, 888-95
  AUTHOR;　Iwanaga K, Sueoka N, Sato A, Hayashi S, Sueoka E
  
• Development of microscopic polyangiitis in patients with chronic airway disease;　2005/10
  ANNOUNCEMENT INFO.;　Lung, 183, 273-81
  AUTHOR;　Takahashi K, Hayashi S, Ushiyama O, Sueoka N, Fukuoka M, Nagasawa K
  
• Clinical significance of the expression of tumor-associated antigen, RCAS1, and its soluble protein in pleural fluid in malignant mesothelioma;　2005/09
  ANNOUNCEMENT INFO.;　Oncol Rep., 14, 357-62
  AUTHOR;　Hiraki A, Aoe K, Murakami T, Nakamura Y, Yamazaki K, Sueoka N, Taguchi K, Kamei T, Maeda T, Takeyama H, Kishimoto T, Nishimura M, Sugi K
  
• Detection of plasma hnRNP B1 mRNA, a new cancer biomarker, in lung cancer patients by quantitative real-time Polymerase Chain Reaction;　2005/04
  ANNOUNCEMENT INFO.;　Lung Cancer, 48, 77-83
  AUTHOR;　Sueoka E, Sueoka N, Iwanaga K, Akemi, Suga K, Hayashi S, Nagasawa K, Nakachi K
  
• A Case of Benign Metastasizing Leiomyoma Diagnosed 10 Years After Hysterectomy;　2004/12
  ANNOUNCEMENT INFO.;　, 44, 7, 773-777
  AUTHOR;　
  
• Presence of Autoantibody against Heterogeneous Nuclear Ribonucleoprotein B1 in Cerebrospinal Fluid of Patients with Relapsing-Remitting Multiple Sclerosis;　2004/12
  ANNOUNCEMENT INFO.;　Ann Neurol., 56, 778-86
  AUTHOR;　Sueoka E, Yukitake M, Iwanaga K, Sueoka N, Aihara T, Kuroda Y
  
• Detection of plasma hnRNP B1 mRNA, a new cancer biomarker, in lung cancer patients by quantitative real-time Polymerase Chain Reaction.;　2004
  ANNOUNCEMENT INFO.;　Lung Cancer in press.
  AUTHOR;　Sueoka E,Sueoka N,Iwanaga K,Akemi S,Suga K,Hayashi S,Nagasawa K,Nakachi K
  
• Presence of Autoantibody against Heterogeneous Nuclear Ribonucleoprotein B1 in Cerebrospinal Fluid of Patients with Relapsing-Remitting Multiple Sclerosis.;　2004
  ANNOUNCEMENT INFO.;　Ann Neurol, 56, 778-86
  AUTHOR;　Sueoka E,Yukitake M,Iwanaga K,Sueoka N,Aihara T,Kuroda Y
  
• Alteration of expression or phosphorylation status of tob, a novel tumor suppressor gene product, is an early event in lung cancer;　2003/12
  ANNOUNCEMENT INFO.;　Cancer Lett., 8, 71-9
  AUTHOR;　Iwanaga K, Sueoka N, Akemi S, Sakuragi T, Sakao Y, Tominaga M, Suzuki T, Yoshida Y, K-Tsuzuku J, Yamamoto T, Hayashi S, Nagasawa K, Sueoka E
  
• Detection and discrimination of preneoplastic and early stages of lung adenocarcinoma using hnRNP B1 combined with the cell cycle-related markers p16, cyclin D1, and Ki-67;　2003/10
  ANNOUNCEMENT INFO.;　Lung Cancer, 40, 45-53
  AUTHOR;　Tominaga M, Sueoka N, Irie K, Iwanaga K, Tokunaga O, Hayashi S, Nakachi K, Sueoka E
  
• Alteration of expression or phosphorylation status of tob, a novel tumor suppressor gene product, is an early event in lung cancer.;　2003
  ANNOUNCEMENT INFO.;　Cancer Letters., 202, 71-79
  AUTHOR;　Iwanaga K,Sueoka N,Sato A,Sakuragi T,Sakao Y,Tominaga M,Suzuki T,Yosida Y，K-Tsuzuka J,Yamamoto T,Hayashi S,Nagasawa K,Sueoka E
  
• Detection and discrimination of preneoplastic and early stages of lung adenocarcinoma using hnRNP B1 combined with the cell cycle-related markers p16, cyclin D1, and Ki-67;　2003
  ANNOUNCEMENT INFO.;　LUNG CANCER, 40, 1, 45-53
  AUTHOR;　Tominaga, M / Sueoka, N / Irie, K / Iwanaga, K / Tokunaga, O / Hayashi, S. i / Nakachi, K / Sueoka, E
  
• Lung cacner prevention with (-)-epigallocatechin gallate using monitoring by heterogeneous nuclear ribonucleoprotein B1;　2002/10
  ANNOUNCEMENT INFO.;　Int. J. Oncol., 20, 1233-1239
  AUTHOR;　Fujimoto N, Sueoka N, Sueoka E, Okabe S, Suganuma M, Harada M, Fujiki H
  
• Cancer prevention with green tea and monitoring by a new biomarker, hnRNP B1;　2001
  ANNOUNCEMENT INFO.;　Mutat. Res. , 481, 299-304
  AUTHOR;　Fujiki H, Suganuma M, Okabe S, Sueoka E, Sueoka N, Fujimoto N, Goto Y, Matsuyama S, Imai K, Nakachi K
  
• Helicobacter Pylori Membrane Protein 1: A new carcinogenic factor of Helicobacter Pylori;　2001
  ANNOUNCEMENT INFO.;　Cancer Res., 61, 6356-6359
  AUTHOR;　Suganuma M, Kurusu M, Okabe S, Sueoka N, Yoshida M, Wakatsuki Y, Fujiki H
  
• Modulation of gene expression by (-)-epigallocatechin gallate in PC-9 cells using a cDNA expression array;　2001
  ANNOUNCEMENT INFO.;　Biol. Pharm. Bull., 24, 883-886
  AUTHOR;　Okabe S, Fujimoto N, Sueoka N, Suganuma M, Fujiki H
  
• hnRNP B1 as early cancer biomarker for occult cancer of human lungs and bronchial dysplasia;　2001
  ANNOUNCEMENT INFO.;　Cancer Res. , 61, 1896-1902
  AUTHOR;　Sueoka E., Sueoka N., Goto Y, Matsuyama S., Nishimura H., Sato M., Fujimura S., Chiba H., and Fujiki H
  
• Insulin-like growth factor binding protein-6 activates programmed cell death in non-small cell lung cancer cells;　2000
  ANNOUNCEMENT INFO.;　Oncogene, 19, 4432-4436
  AUTHOR;　Sueoka N, Lee HY, Wiehle S, Cristino RJ, Fang B, Ji L, Roth JA, Hong WK, Cohen P, and Kurie JM
  
• Heterogeneous nuclear ribonucleoprotein B1 expressed in esophageal squamous cell carcinomas as a new biomarker for Diagnosis;　2000
  ANNOUNCEMENT INFO.;　Jpn. J. Cancer Res., 91, 658-663
  AUTHOR;　Matsuyama S, Goto Y, Sueoka N, Ohkura Y, Tanaka Y, Nakachi K, Sueoka E
  
• Mechanisms of cancer prevention by tea polyphenols based on inhibition of TNF- expression;　2000
  ANNOUNCEMENT INFO.;　BioFactors, 13, 67-72
  AUTHOR;　Suganuma M, Sueoka E, Sueoka N, Okabe S, Fujiki H
  
• Post-translational mechanisms contribute to the suppression of specific cyclin:CDK complexes by all-trans retinoic acid in human bronchial epithelial cells;　1999
  ANNOUNCEMENT INFO.;　 Cancer Res., 59, 3838-3844
  AUTHOR;　Sueoka N, Lee HY, Walsh GL, Hong WK, Kurie JM
  
• Heterogeneous nuclear ribonucleoprotein B1 as a new marker of early detection for human lung cancers;　1999
  ANNOUNCEMENT INFO.;　Cancer Res., 59, 1404-1407
  AUTHOR;　Sueoka E, Goto Y, Sueoka N, Kai Y, Kozu T, and Fujiki H
  
• Synergistic effects of (--)-epigallocatechin gallate with (--) epicatechin, sulindac, or tamoxifen on caner-preventive activity in the human lung cancer cell line PC-9;　1999
  ANNOUNCEMENT INFO.;　Cancer Res., 59, 44-47
  AUTHOR;　Suganuma M, Okabe S, Kai Y, Sueoka N, Sueoka E, Fujiki H
  
• Green tea and cancer chemoprevention;　1999
  ANNOUNCEMENT INFO.;　Mutat. Res., 428, 339-344
  AUTHOR;　Suganuma M, Okabe S, Sueoka N, Sueoka E, Matsuyama S, Imai K, Nakachi K, and Fujiki H
  
• All-trans retinoic acid inhibits Jun N-terminal kinase by increasing dual-specificity phosphatase activity;　1999
  ANNOUNCEMENT INFO.;　Mol. Cell. Biol., 19, 1973-1980
  AUTHOR;　Lee HY, Sueoka N, Hong WK, Mangelsdorf DJ, Claret FX, Kurie JM
  
• Molecular pathogenesis of interstitial pneumonitis with TNF- transgenic mice;　1998
  ANNOUNCEMENT INFO.;　Cytokine, 10, 124-131
  AUTHOR;　Sueoka N, Sueoka E, Miyazaki Y, Okabe S, Kurosumi M, Takayama S, Fujiki H
  
• Anticancer activity of morphine and its synthetic derivative, KT 90, mediated through apoptosis and inhibition of NF-kB activation;　1998
  ANNOUNCEMENT INFO.;　Biochem. Biophysic. Res. Comm., 252, 566-570
  AUTHOR;　Sueoka E, Sueoka N, Kai Y, Okabe S, Suganuma M, Kanematsu K, Yamamoto T, and Fujiki H
  
• Tumourigenicity of MTG8, a leukemia-related gene, in concert with v-Ha-ras gene in BALB/3T3 cells;　1998
  ANNOUNCEMENT INFO.;　Br. J. Haematol., 101, 737-742
  AUTHOR;　Sueoka E, Sueoka N, Okabe S, Komori A, Suganuma M, Kozu T, Fujiki H
  
• Cancer inhibition by green tea;　1998
  ANNOUNCEMENT INFO.;　Mutat. Res., 402, 307-310
  AUTHOR;　Fujiki H, Suganuma M, Okabe S, Sueoka N, Komori A, Sueoka E, Kozu T, Tada Y, Suga K, Imai K, Nakachi K
  
• Phase I clinical trial with green tea tablets in a Japanese healthy population;　1998
  ANNOUNCEMENT INFO.;　Cancer Prevention International, 3, 79-88
  AUTHOR;　Suga K, Imai K, Sueoka N, Nakachi K
  
• Twist form of teleocidin derivatives is active in in vivo tumor promotion by (-)-bezolactam-V8-310;　1998
  ANNOUNCEMENT INFO.;　Biol. Pharm. Bull., 21, 465-468
  AUTHOR;　Okabe S, Sueoka N, Komori A, Suganuma M, Endo Y, Shudo K, Fujiki H
  
• Expression of the tumor necrosis factor a gene and early response genes by nodularin, a liver tumor promoter, in primary cultured rat hepatocytes;　1997
  ANNOUNCEMENT INFO.;　J. Cancer Res. Clin. Oncol., 123, 413-419
  AUTHOR;　Sueoka E, Sueoka N, Okabe S, Kozu T, Komori A, Ohta T, Suganuma M, Kim S-J Lim IK, Fujiki H
  
• Designing of chimeric DNA/RNA hammerhead ribozymes to be targeted against AML1/MTG8 mRNA;　1996
  ANNOUNCEMENT INFO.;　J. Cancer res. Clin. Oncol., 122, 254-256
  AUTHOR;　Kozu T, Sueoka E, Okabe S, Sueoka N, Komori A, Fujiki H
  
• In vitro catalytic activities of DNA/RMA chimeric hammerhead ribozymes against AML1-MTG8 mRNA, a fused gene transcript in acute myeloid leukemia with t(8;21);　1996
  ANNOUNCEMENT INFO.;　Biochimie., 78, 1067-1073
  AUTHOR;　Kozu T, Sueoka E, Okabe S, Sueoka N, Komori A, Fujiki H
  
• Japanese green tea as a cancer preventive in humans;　1996
  ANNOUNCEMENT INFO.;　Nutrition Reviews, 54, S1-S4
  AUTHOR;　Fujiki H, Suganuma M, Okabe S, Komori A, Sueoka E, Sueoka N, Kozu T, Sakai Y
  
• Anti-cancer effects of morphine through inhibition of tumor necrosis factor- release and mRNA expression.;　1996
  ANNOUNCEMENT INFO.;　Carcinogenesis, 17, 2337-2341
  AUTHOR;　Sueoka N, Sueoka E, Okabe S, Fuiki H
  
• Significance of marine Toxins in tumor promotion of carcinogenesis. Molecular Approaches to Food Safety Issues Involving Toxic Microorganisms;　1996
  ANNOUNCEMENT INFO.;　, 367-381
  AUTHOR;　Fujiki H, Suganuma M, Okabe, Komori A, Sueoka E, Kozu T, Sueoka N, Morita T
  
• Green tea is a cancer preventive in humans;　1996
  ANNOUNCEMENT INFO.;　Proc. First Int. Conf. East West Perspectives on Functional Foods
  AUTHOR;　Fujiki H, Suganuma M, Okabe S, Komori A, Sueoka E, Sueoka N, Kozu T, Sakai 　Y
  
• Expression of early response genes by nodularin, a new liver carcinogen, through inhibition of protein phosphatases 1 and 2A;　1996
  ANNOUNCEMENT INFO.;　Proc. 7th International Conf. Toxic Phytoplankton
  AUTHOR;　Sueoka E, Sueoka N, Komori A, Okabe S, Kozu T, Suganuma M, Fujiki H
  
• Basicstudy of cancer chemopreventive agents;　1996
  ANNOUNCEMENT INFO.;　Proc. International Symposium on the Development Appl. Chemo. Agents, Korea
  AUTHOR;　Suganuma M, Okabe S, Komori A, Sueoka E, Sueoka N, Fujiki H.
  
• Biol. Bull.;　1995
  ANNOUNCEMENT INFO.;　, 189, 201
  AUTHOR;　Troll W, Sueoka N, Sueoka E, Laskin JD, Heck DE
  
• Determination of various cytokins and type III procollagen aminopeptide levels in bronchoalveolar lavage fluid of the patients with pulmonary fibrosis;　1995
  ANNOUNCEMENT INFO.;　Br. J. Rheumatol., 34, 31-36
  AUTHOR;　Kuroki S, Ohta A, Sueoka N, Katoh O, Yamada H, Yamaguchi M
  
• Fiberoptic bronchoscopy in inhalation of injury;　1994
  ANNOUNCEMENT INFO.;　, 16, 454-460
  AUTHOR;　
  
• Study of two cases of active pulmonary tuberculosis complicated by lung cancer;　1994
  ANNOUNCEMENT INFO.;　, 69, 323-328
  AUTHOR;　
  
• Successful treatment of autoimmune thrombocytopenia and rapid progressive pneumonitis with recurrent pneumothorax in a patient with rheumatoid arthritis;　1993
  ANNOUNCEMENT INFO.;　Br. J. Rheumatol., 32, 855-856
  AUTHOR;　Kuroki S, Ohta A, Katoh O, Sueoka N, Yamada H, Yamaguchi M
  
• A case of extraskeletal Ewing's sarcoma of the chest wall;　1993
  ANNOUNCEMENT INFO.;　, 31, 872-875
  AUTHOR;　
  
• A case of cardiac sarcoidosis associated with various clinical symptoms and thrombocytopenia;　1992
  ANNOUNCEMENT INFO.;　, 30, 2146-2150
  AUTHOR;　
  
• Respiratory failure due to vocal cord dyskinesia in olivo-ponto cerebellar atrophy;　1989
  ANNOUNCEMENT INFO.;　Chest, 96, 1212-1214
  AUTHOR;　Aragane N, Katoh O, Yamada H, Kuroda Y, Maeyama T
  

Material, Commentary, Editorials, Research Report, A Comprehensive Journal Articles

• A 45-Year-Old Woman With Unexplained Iron Deficiency Anemia and No Respiratory Symptoms;　2023/01
  ANNOUNCEMENT INFO.;　Chest, 163, 1, e7-e11
  AUTHOR;　Kuwahara Y, Tashiro H, Takahashi K, Kimura S, Sueoka-Aragane N
  
• A 45-Year-Old Man With Acute Chest Pain, Fever, and Dyspnea After Tooth Extraction ;　2021/12
  ANNOUNCEMENT INFO.;　Chest, 160, 6, e623-e628
  AUTHOR;　Hiroki Tashiro, Koichiro Takahashi, Tetsuro Haraguchi, Kazuki Jinnouchi, Shinya Kimura, Naoko Sueoka-Aragane
  
• Idiopathic eosinophilic pleurisy: A practical diagnostic approach ;　2021/05
  ANNOUNCEMENT INFO.;　Respir Med Case Rep, 33, 101430
  AUTHOR;　*Tetsuro Haraguchi, Hiroki Tashiro, Koichiro Takahashi, Yuki Kurihara, Hironori Sadamatsu, Naofumi Miyahara, Masafumi Hiratsuka, Shinya Kimura, Naoko Sueoka-Aragane
  
• Clinical Manifestations of Allergic Bronchopulmonary Aspergillosis without Major Features of Asthma Diagnosed by the New Criteria in Japan;　2021/04
  ANNOUNCEMENT INFO.;　Intern Med, 60, 8, 1251-1255
  AUTHOR;　Yuki Kurihara, Hiroki Tashiro, Koichiro Takahashi, Natsuko Komiya, Hironori Sadamatsu, Shinya Kimura, Naoko Sueoka-Aragane
  
• Acute Generalized Exanthematous Pustulosis Caused by Erlotinib in a Patient with Lung Cancer ;　2021/03
  ANNOUNCEMENT INFO.;　Case Rep Oncol, 14, 1, 599-603
  AUTHOR;　Natsuko Komiya, Koichiro Takahashi, Go Kato, Mio Kubota, Hiroki Tashiro, Chiho Nakashima, Tomomi Nakamura, Kentaro Iwanaga, Shinya Kimura, Naoko Sueoka-Aragane
  
• Efficacy of dupilumab and biomarkers for systemic corticosteroid naïve allergic bronchopulmonary mycosis;　2021/01
  ANNOUNCEMENT INFO.;　Allergol Int, 70, 1, 145-147
  AUTHOR;　Hiroki Tashiro, Koichiro Takahashi, Yuki Kurihara, Hironori Sadamatsu, Shinya Kimura, Naoko Sueoka-Aragane
  
• A rare case of Trichosporon mycotoxinivorans and Cryptococcus neoformans co-infection in lung;　2020/08
  ANNOUNCEMENT INFO.;　J Infect Chemother, 26, 8, 838-842
  AUTHOR;　Hironori Sadamatsu, Koichiro Takahashi, Hiroki Tashiro, Shinsuke Ogusu, Tetsuro Haraguchi, Chiho Nakashima, Tomomi Nakamura, Naoko Sueoka-Aragane
  
• Eosinophilic granulomatous polyangiitis with IgG4 hypergammaglobulinaemia and salivary gland swelling;　2020/03
  ANNOUNCEMENT INFO.;　Respirol Case Rep, 8, 4, e00552
  AUTHOR;　Koichiro Takahashi, Hironori Sadamatsu, Hiroki Tashiro, Go Kato, Masaru Uchida, Naoko Sueoka-Aragane
  
• Mesalazine-induced airway obstruction: Utility of pulmonary function testing in drug-induced lung diseases.;　2019/11
  ANNOUNCEMENT INFO.;　Respir Investig. , 57, 6, 611-614
  AUTHOR;　Hirakawa H, Tashiro H, Takahashi K, Tanaka M, Sadamatsu H, Kimura S, Sueoka-Aragane N.
  
• Paraneoplastic Limbic Encephalitis Complicated with Small Cell Lung Cancer at the Time of Recurrence.;　2019/06
  ANNOUNCEMENT INFO.;　Case Rep Oncol. , 12, 2, 466-472
  AUTHOR;　Sadamatsu H, Kurihara Y, Takahashi K, Komiya K, Ogusu S, Hirakawa H, Tashiro H, Nakashima C, Nakamura T, Sueoka-Aragane N.
  
• A case of osimertinib-resistant lung adenocarcinoma responded effectively to alternating therapy.;　2018
  ANNOUNCEMENT INFO.;　Ann Transl Med. , 6, 23, 464
  AUTHOR;　Hirakawa H, Komiya K, Nakashima C, Ogusu S, Nakamura T, Tanaka M, Takahashi K, Egashira Y, Kai K, Kimura S. Sueoka-Aragane N
  
• Primary Pulmonary Colloid Adenocarcinoma: How Can We Obtain a Precise Diagnosis?;　2018
  ANNOUNCEMENT INFO.;　Intern Med. , 57, 24, 3637-3641
  AUTHOR;　Ogusu S, Takahashi K, Hirakawa H, Tanaka M, Komiya K, Nakamura T, Egashira R, Kai K, Takeda Y, Kimura S, Sueoka-Aragane N
  
• Successful Surgical Resection following Bronchial Artery Embolization in a Case of Lung Cancer Complicated with Massive Hemoptysis.;　2018
  ANNOUNCEMENT INFO.;　Case Rep Oncol. , 11, 1, 125-130
  AUTHOR;　Sadamatsu H, Takahashi K, Inoue H, Umeguchi H, Koga S, Kuroki H, Akashi M, Kato M, Sueoka-Aragane N
  
• Necrotizing Sarcoid Granulomatosis with Natural Resolution after a Surgical Lung Biopsy.;　2018
  ANNOUNCEMENT INFO.;　Intern Med. , 57, 11, 1625-1629
  AUTHOR;　*Shibata T, Takahashi K, Uchida M, Yamasaki F, Kawashima M, Sueoka-Aragane N
  
• Sj?gren Syndrome Complicated with Cystic Lung Disease and Pulmonary Amyloidosis. ;　2018
  ANNOUNCEMENT INFO.;　Case Rep Rheumatol. , 2018, 7475242
  AUTHOR;　Takahashi K, Sadamatsu H, Ogusu S, Komiya K, Nakamura T, Kimura S, Sueoka-Aragane N
  
• Signet Ring Cell Carcinoma of Unknown Primary Complicated with Pulmonary Tumor Thrombotic Microangiopathy and Krukenberg Tumor. ;　2018
  ANNOUNCEMENT INFO.;　Case Rep Oncol. , 11, 2, 412-417
  AUTHOR;　Tanaka M, Takahashi K, Kurihara Y, Yamamoto-Rikitake M, Ogusu S, Hirakawa H, Sadamatsu H, Komiya K, Nakamura T, Sueoka-Aragane N
  
• Coexistence of lung cancer and immunoglobulin G4-related lung disease in a nodule: a case report.;　2016
  ANNOUNCEMENT INFO.;　J Med Case Rep., 10, 1, 113
  AUTHOR;　Tashiro H, Takahashi K, Nakamura T, Komiya K, Kimura S. Sueoka-Aragane N.
  
• Chronic and Asymptomatic Diffuse Alveolar Haemorrhage with Microscopic Polyangiitis: A Case Report and Review of the Literature.;　2016
  ANNOUNCEMENT INFO.;　Case Rep Rheumatol., 2016, 1658126
  AUTHOR;　Tashiro H, Takahashi K, Sadamatsu H, Uchida M, Kimura S, Sueoka-Aragane N
  
• A case of relapsing polychondritis successfully treated with combination of a glucocorticoid and cyclosporine.;　2015
  ANNOUNCEMENT INFO.;　Int J Clin Med, 6, 7, PP. 439-443
  AUTHOR;　Takahashi K, Inoue H, Sadamatsu H, Umeguchi H, Sueoka-Aragane N, Kimura S
  
• Insulin-like growth factor binding protein-6 inhibits the growth of human bronchial epithelial cells and increases in abuncance with all-trans retinoic acid treatment;　2000
  ANNOUNCEMENT INFO.;　Am. J. Respir. Cell Mol. Biol., 23, 297-303
  AUTHOR;　Sueoka N, Lee HY, Walsh GL, Fang B, Ji L, Roth JA, LaPushin R, Hong WK, Cohen P, Kurie JM
  

General Lectures

• A phase 2 basket trial of combination therapy with trastuzumab and pertuzumab in patients with solid cancers harboring HER2 amplification (JUPITER trial) ;　2021/06
  ANNOUNCEMENT INFO.;　2021 ASCO Annual Meeting (Virtual Meeting), 2021, 6, 4-8
  AUTHOR;　*Ryo Kudo, Toshio Kubo, Yukiko Mori, Yohei Harada, Hidekazu Shirota, Hideyuki Hayashi, Masayuki Kano, Yasushi Shimizu, Eri Ishibashi, Hirotoshi Akita, Hisahiro Matsubara, Hiroshi Nishihara, Chikashi Ishioka, Naoko Sueoka-Aragane, Manabu Muto, Shinichi Toyooka, Ukihide Tateishi, Akihiro Hirakawa, Satoshi Miyake, Sadakatsu Ikeda
  
• Tiotropium/olodaterol reduces sedentary behavior in patients with treatment-na?ve chronic obstructive pulmonary disease;　2021/05
  ANNOUNCEMENT INFO.;　ATS 2021 International Conference (Virtual), 2021, 5,14-19
  AUTHOR;　Koichiro Takahashi, Hiroki Tashiro, Ryo Tajiri, Ayako Takamori, Hironori Sadamatsu, Masaru Uchida, Go Kato, Takashi Kinoshita, Makoto Yoshida, Atsushi Kawaguchi , Shinya Kimura, Naoko Sueoka-Aragane, Tomotaka Kawayama
  
• The clinical outcomes of nivolumab plus ipilimumab combined with platinum-based chemotherapy, single-center, retrospective analysis;　2021
  ANNOUNCEMENT INFO.;　APSR 2021-The 25th Congress of the Asian Pacific Society of Respirology (Hybrid event), 2021,11,20-21(On-site, Virtual Live), 2021,11,22-12,28(On-demand)
  AUTHOR;　Natsuko Komiya, Chiho Nakashima, Yuuki Kuwahara, Hironori Sadamatsu, Yuuki Kurihara, Hiroki Tashiro, Tomomi Nakamura, Koichiro Takahashi, Shinya Kimura, Naoko Sueoka-Aragane
  
• Initial treatment with tiotropium/olodaterol improves physical inactivity in patients with treatment-naïve COPD;　2020/09
  ANNOUNCEMENT INFO.;　ERS International Congress 2020 (Virtual meeting), 2020, 9, 7 - 9
  AUTHOR;　Koichiro Takahashi, Masaru Uchida, Go Kato, Ayako Takamori, Hironori Sadamatsu, Masahide Tanaka, Ryo Tajiri, Hiroshi Inoue, Takashi Kinoshita, Keisuke Kojima, Makoto Yoshida, Hiromi Kobayashi, Hiroki Tashiro, Shinichiro Hayashi, Atsushi Kawaguchi, Naoko Sueoka-Aragane, Tomotaka Kawayama
  
• Blood Eosinophils at the Stable Period are a Biomarker of Frequent Exacerbation for Japanese Patients with COPD;　2020
  ANNOUNCEMENT INFO.;　JSA/WAO Joint Congress 2020 (Web開催）, 2020. 9. 17（一部ライブ配信）, 2020. 9. 17-10. 20（オンデマンド配信）
  AUTHOR;　Yuki Kurihara, Hiroki Tashiro , Koichiro Takahashi, Hironori Sadamatsu, Chiho Nakashima, Tomomi Nakamura, Naoko Sueoka-Aragane
  
• The Non-Antibiotic Macrolide EM900 attenuates HDM-induced airway inflammation in Obese Asthma Model;　2020
  ANNOUNCEMENT INFO.;　JSA/WAO Joint Congress 2020 (Web開催）, 2020. 9. 17（一部ライブ配信）, 2020. 9. 17-10. 20（オンデマンド配信）
  AUTHOR;　Sadamatsu H, Takahashi K, Tashiro H, Kurihara Y, Kato G, Uchida M, Kurata K, Noguchi Y, Kimura S, Sunazuka T, Sueoka-Aragane N
  
• Tiotropium/olodaterol improves pulmonary function and physical activity in patients with treatment-naïve COPD;　2020
  ANNOUNCEMENT INFO.;　ATS 2020 (Virtual Conference), 2020, 8, 5-10 (until 11,10)
  AUTHOR;　Koichiro Takahashi, Masaru Uchida, Go Kato, Ayako Takamori, Hironori Sadamatsu, Masahide Tanaka, Ryo Tajiri, Hiroshi Inoue, Takashi Kinoshita, Keisuke Kojima, Makoto Yoshida, Hiromi Kobayashi, Hiroki Tashiro, Shinichiro Hayashi, Atsushi Kawaguchi, Naoko Sueoka-Aragane, Tomotaka Kawayama
  
• Microbiome contribute to increase pulmonary response to ozone in obese mice;　2020
  ANNOUNCEMENT INFO.;　JSA/WAO Joint Congress 2020 (Web開催）, 2020. 9. 17（一部ライブ配信）, 2020. 9. 17-10. 20（オンデマンド配信）
  AUTHOR;　Hiroki Tashiro, Koichiro Takahashi, Hironori Sadamatsu, Yuki Kurihara, Naoko Sueoka-Aragane, Lynn Bry, Stephanie A. Shore
  
• Clinical characteristics and biomarker for Japanese asthmatic patients with obesity;　2020
  ANNOUNCEMENT INFO.;　JSA/WAO Joint Congress 2020 (Web開催）, 2020. 9. 17（一部ライブ配信）, 2020. 9. 17-10. 20（オンデマンド配信）
  AUTHOR;　Hiroki Tashiro, Koichiro Takahashi, Hironori Sadamatsu, Yuki Kurihara, Sinya Kimura, Naoko Sueoka-Aragane
  
• Characteristics of circulating tumor DNA in lung cancer patients.;　2019
  ANNOUNCEMENT INFO.;　AACR Annual Meeting 2019, 2019, 3, 29-4, 3
  AUTHOR;　Abe T, Nakashima C, Sato A, Harada Y, Sueoka E, Kimura K, Sueoka-Aragane N.
  
• How does circulating turmor DNA exist in peripheral blood?;　2019
  ANNOUNCEMENT INFO.;　78th Annual Meeting of the Japanese Cancer Association, 2019, 9, 26-28
  AUTHOR;　Abe T, Nakashima C, Sato A, Harada Y, Sueoka E, Kimura K, Sueoka-Aragane N.
  
• Investigation of mechanisms of acquired resistance to afatinib with plasma DNA in non-small cell lung cancer patients.;　2019
  ANNOUNCEMENT INFO.;　IASLC 2019 World Conference on Lung Cancer, 2019, 9, 7-10
  AUTHOR;　Naoko Aragane, Tomomi Nakamura, Kazutoshi Komiya, Chiho Nakashima, Kentarou Iwanaga, Hitomi Umeguchi.
  
• Analysis of a novel variant of HER2 detected by clinical sequencing in cancer of unknown primary;　2019
  ANNOUNCEMENT INFO.;　AACR Annual Meeting 2019, 2019, 3, 29-4, 3
  AUTHOR;　Harada Y, Sato A, Abe T, Nakashima C, Sueoka E, Kimura K, Sueoka-Aragane N.
  
• Analysis of a novel variant of extracellular domain of HER2 detected by clinical sequencing in cancer of unknown primary. ;　2019
  ANNOUNCEMENT INFO.;　78th Annual Meeting of the Japanese Cancer Association, 2019, 9, 26-28
  AUTHOR;　Harada Y, Sato A, Abe T, Nakashima C, Sueoka E, Kimura K, Sueoka-Aragane N.
  
• Prospective study for usefulness of plasma DNA on prediction of third generation EGFR tyrosine kinase inhibitors (S-PLAT study);　2019
  ANNOUNCEMENT INFO.;　IASLC 2019 World Conference on Lung Cancer, 2019, 9, 7-10
  AUTHOR;　Nakashima C, Yoshida K, Matsumoto N, Iwanaga K, Ebi N, Nishiyama A, Yatera K, Kuyama S, Fukuda M, Ushijima S, Umeguchi H, Harada D, Kashiwabara K, Suetsugu T, Fujimoto N, Tanaka F, Uramoto H, Yoshii C, Nakatomi K, Nosaki K, Ichikawa Y, Aoe K, Inoue K, Takayama K, Kato M, Sueoka-Aragane N.
  
• Prospective study for usefulness of plasma DNA on prediction of third generation EGFR tyrosine kinase inhibitors.;　2019
  ANNOUNCEMENT INFO.;　78th Annual Meeting of the Japanese Cancer Association, 2019, 9, 26-28
  AUTHOR;　Nishiyama A, Aragane N. Yoshida K, Matsumoto N, Iwanaga K, Ebi N, Yatera K
  
• An effect of novel non-antibiotic macrolide EM900 in HDM-induced airway inflammation mice model;　2019
  ANNOUNCEMENT INFO.;　ATS2019, 2019, 5, 17-22
  AUTHOR;　Sadamatsu H, Takahashi K, Tashiro H, Noguchi Y, ?mura S, Kimura S, Sunazuka T, Sueoka-Aragane N
  
• Tiotropium/olodaterol improves pulmonary function in patients with treatment naïve COPD;　2019
  ANNOUNCEMENT INFO.;　ERS International Congress 2019, 2019, 9, 28-10, 2
  AUTHOR;　Koichiro Takahashi, Masaru Uchida, Go Kato, Ayako Takamori, Hironori Sadamatsu, Masahide Tanaka, Ryo Tajiri, Takashi Kinoshita, Keisuke Kojima, Makoto Yoshida, Hiroki Tashiro, Shinichiro Hayashi, Atsushi Kawaguchi, Naoko Sueoka-Aragane, Tomotaka Kawayama
  
• Characteristics of circulating tumor DNA in lung cancer patients. ;　2018
  ANNOUNCEMENT INFO.;　AACR Annual Meeting 2018, 2018, 4,14-18
  AUTHOR;　Abe T, Nakashima C, Sato A, Sueoka E, Kimura S, Sueoka-Aragane N
  
• irAE, Possible Predictive Markers for Immune Checkpoint Inhibitors;　2018
  ANNOUNCEMENT INFO.;　IASLC 19th WORLD CONFERENCE ON LUNG CANCER, 2018, 9,23-26
  AUTHOR;　Kazutoshi Komiya, Tomomi Nakamura, Haruki Hirakawa, Shinsuke Ogusu, Chiho Nakashima, Koichiro Takahashi, Shinya Kimura, Naoko Sueoka-Aragane.
  
• Mechanisms of acquired resistance to afatinib clarified with liquid biopsy;　2018
  ANNOUNCEMENT INFO.;　IASLC 19th WORLD CONFERENCE ON LUNG CANCER, 2018, 9,23-26
  AUTHOR;　Tomomi Nakamura, Chiho Nakashima, Kazutoshi Komiya, Kimura S, Sueoka-Aragane N
  
• Investigation of origin of circulating free DNA: Is exosomal DNA the carrier?;　2018
  ANNOUNCEMENT INFO.;　AACR Annual Meeting 2018, 2018, 4,14-18
  AUTHOR;　Nakashima C, Abe T, Sato A, Nakamura T, Komiya K, Sueoka E, Kimura S, Sueoka-Aragane N
  
• Investigation of origin of circulating free DNA: Is EV the carrier? ;　2018
  ANNOUNCEMENT INFO.;　The 14th Japan-Korea Joint Symposium on Cancer and Ageing Research, 2018, 5, 31- 6,2
  AUTHOR;　Nakashima C, Sato A, Abe T, Nakamura T, Komiya K, Sueoka E, Kimura S, Sueoka-Aragane N
  
• An Effect of Clarthromycin Treatment in HDM-Induced Allergic Airway Inflammation in Mice;　2018
  ANNOUNCEMENT INFO.;　ATS 2018, 2018, 5, 18-23
  AUTHOR;　Sadamatsu H, Takahashi K, Tashiro H, Kato G, Uchida M, Kimura S, Sueoka-Aragane N.
  
• Characteristics of circulating free DNA in lung cancer patients. ;　2018
  ANNOUNCEMENT INFO.;　The 77th Annual Meeting of the Japanese Cancer Association, 2018, 9, 27-29
  AUTHOR;　Tomonori Abe, Chiho Nakashima, Akemi Sato, Yohei Harada, Eisaburo Sueoka, Shinya Kimura, Naoko Aragane.
  
• Analysis of a novel mutation of ERBB2 in cancer of unknown primary;　2018
  ANNOUNCEMENT INFO.;　The 77th Annual Meeting of the Japanese Cancer Association, 2018, 9, 27-29
  AUTHOR;　
  
• Investigation of origin of circulating free DNA: Are extracellular vesicles the carrier?;　2018
  ANNOUNCEMENT INFO.;　The 77th Annual Meeting of the Japanese Cancer Association, 2018, 9, 27-29
  AUTHOR;　Chiho Nakashima, Tomonori Abe, Yohei Harada, Akemi Sato, Tomomi Nakamura, Kazutoshi Komiya, Eisaburo Sueoka, Shinya Kimura, Naoko Sueoka-Aragane
  
• Characteristics of cell free DNA in lung cancer patients.;　2017
  ANNOUNCEMENT INFO.;　IASLC 18th WORLD CONFERENCE ON LUNG CANCER, 2017,10,15-18
  AUTHOR;　Tomonori Abe, Chiho Nakashima, Akemi Sato, Eisaburo Sueoka, Shinya Kimura, Naoko Aragane.
  
• Characteristics of cell free DNA in lung cancer patients.;　2017
  ANNOUNCEMENT INFO.;　The 76th Annual Meeting of the Japanese Cancer Association, 2017.9.28-30
  AUTHOR;　Tomonori Abe, Chiho Nakashima, Naomi Watanabe, Akemi Sato, Eisaburo Sueoka, Shinya Kimura, Naoko Aragane.
  
• Liquid biopsy for genomic alterations (Discussant).;　2017
  ANNOUNCEMENT INFO.;　IASLC 18th WORLD CONFERENCE ON LUNG CANCER, 2017,10,15-18
  AUTHOR;　Aragane N.
  
• Correlation and problems of re-biopsy and liquid biopsy for detecting T790M mutation.;　2017
  ANNOUNCEMENT INFO.;　IASLC 18th WORLD CONFERENCE ON LUNG CANCER, 2017,10,15-18
  AUTHOR;　Kazutoshi Komiya, Tomomi Nakamura, Momoko Hayase, Haruki Hirakawa, Shinsuke Ogusu, Tomonori Abe, Chiho Nakashima, Koichiro Takahashi, Yuji Takeda, Kimura S, Sueoka-Aragane N.
  
• Clarification of mechanisms of acquired resistance for afatinib using plasma samples.;　2017
  ANNOUNCEMENT INFO.;　IASLC 18th WORLD CONFERENCE ON LUNG CANCER, 2017,10,15-18
  AUTHOR;　Tomomi Nakamura, Chiho Nakashima, Kazutoshi Komiya, Kimura S, Sueoka-Aragane N.
  
• DNA extraction method using cellulose magnetic beads can improve the EGFR mutation detection rate.;　2017
  ANNOUNCEMENT INFO.;　The 76th Annual Meeting of the Japanese Cancer Association, 2017.9.28-30
  AUTHOR;　Chiho Nakashima, Tomonori Abe, Akemi Sato, Eisaburo Sueoka, Shinya Kimura, Naoko Aragane
  
• Automatic DNA extraction system can improve the EGFR point mutation detection rate of liquid biopsy.;　2017
  ANNOUNCEMENT INFO.;　American Association for Cancer Research Annual Meeting 2017, 2017, 4, 1-5
  AUTHOR;　Nakashima C, Sato A, Abe T, Nakamura T, Komiya K, Sueoka E, Kimura K, Aragane N.
  
• Recruited lung macrophages contribute to progression of airway inflammation in obesity asthma mice model. ;　2017
  ANNOUNCEMENT INFO.;　American Thoracic Society 2017 International Conference, May 19-24, 2017, Washington, D.C.
  AUTHOR;　Hiroki Tashiro, Hironori Sadamatsu, Koichiro Takahashi, Go Kato, Shinya Kimura, Naoko Sueoka-Aragane.
  
• IL-33 from inflammatory monocytes recruited to lung contributes to HDM-Induced airway inflammation;　2016
  ANNOUNCEMENT INFO.;　The 65th Annual Meeting of Japanese Society of Allergology (English oral session), 2016.6.17-19
  AUTHOR;　Hiroki Tashiro, Koichiro Takahashi, Go Kato, Shinichiro Hayashi, Shinya Kimura, Naoko Sueoka-Aragane
  
• A case of rapidly progressive primary mixed-type germ cell tumor of the mediastinum after induction chemotherapy;　2016
  ANNOUNCEMENT INFO.;　2016 the Japanese Society of Medical Oncology Annual Meeting, 2016.7.28-30
  AUTHOR;　Hirakawa H, Komiya K, Kurihara Y, Sadamatsu H, Nakashima C, Nakamura T, Takahashi K, Kimura K, and Aragane N
  
• Functional analysis of Discoidin domain receptor 2 mutation and expression in squamous cell lung cancer;　2016
  ANNOUNCEMENT INFO.;　AACR Annual Meeting 2016, 2016, April 16-20
  AUTHOR;　Watanabe-Kobayashi N, Sato A, Watanabe T, Sueoka E, Kimura S, Sueoka-Aragane N
  
• IL-33 from inflammatory monocytes recruited to lung contributes to HDM-Induced airway inflammation;　2016
  ANNOUNCEMENT INFO.;　ATS International Conference 2016, 2016, May, 13-18
  AUTHOR;　H. Tashiro, K. Takahashi, G. Kato, S. Hayashi, S. Kimura, N. Sueoka-Aragane
  
• Functional analysis of Discoidin domain receptor 2 mutation and expression in squamous cell lung cancer;　2016
  ANNOUNCEMENT INFO.;　The 75th Annual Meeting of the Japanese Cancer Association, October 6-8, 2016
  AUTHOR;　Naoko Sueoka-Aragane, Naomi Watanabe, Akemi Sato, Tatsuro Watanabe, Eisaburo Sueoka, Shinya Kimura
  
• An analysis of pulmonary manifestations of IgG4-Related Disease;　2016
  ANNOUNCEMENT INFO.;　ATS International Conference 2016, 2016, May, 13-18
  AUTHOR;　H. Sadamatsu, K. Takahashi, H. Tashiro, N. Sueoka-Aragane
  
• Investigation of mechanism of lymphogenous metastasis using human lung cancer metastatic animal model;　2016
  ANNOUNCEMENT INFO.;　The 75th Annual Meeting of the Japanese Cancer Association, October 6-8, 2016
  AUTHOR;　Chiho Nakashima, Akemi Sato, Shinya Kimura, Naoko Aragane
  
• Investigation of mechanism of lymphogenous metastasis using human lung cancer metastatic animal model;　2016
  ANNOUNCEMENT INFO.;　The 13th Korea-Japan Joint Symposium on Cancer and Ageing Research 2016, 2016, February 25-27
  AUTHOR;　Nakashima C, Sato A, Sueoka E, Okada S, Kimura K, Aragane N
  
• A retrospective analysis of the efficacy and safety of ALK inhibitors in ALK-positive lung cancer patients;　2016
  ANNOUNCEMENT INFO.;　IASLC 17th WORLD CONFERENCE ON LUNG CANCER, 2016.12.4-7
  AUTHOR;　Komiya K, Nakamura T, Kurihara Y, Hirakawa H, Sadamatsu H, Nakashima C, Umeguchi H, Takeda Y, Kimura S, Sueoka-Aragane N
  
• A case with cancer of unknown primary diagnosed pathologically retroperitoneal squamous cell carcinoma.;　2015
  ANNOUNCEMENT INFO.;　The Japanese Society of Medical Oncology 2015 Annual Meeting, 2015.7.16-18
  AUTHOR;　Hiroaki Kitamura, Tomomi Kashiwada, Kazutoshi Komiya, YukihikoNakayma, Takahiko Nakazono, Yukari Takase, Naoko Aragane, Shinya Kimura
  
• Monocytes IL-33 contributes to HDM-induced allergic airway inflammation;　2015
  ANNOUNCEMENT INFO.;　American Thoracic Society 2015 International Conference in Denver, 2015, 5, 15-20
  AUTHOR;　Hiroki Tashiro, Koichiro Takahashi, Go Kato, Naoko Sueoka-Aragane, Shinya Kimura ,Shinichiro Hayashi
  
• SPARC, a possible predictive marker to albumin-bound paclitaxel (nab-paclitaxel) in non-small cell lung cancer;　2015
  ANNOUNCEMENT INFO.;　16th World Conference on Lung Cancer, 2015.9.6-9
  AUTHOR;　Kazutoshi Komiya, Tomomi Nakamura, Hironori Sadamatsu, Chiho Nakashima, Koichiro Takahashi, Hitomi Umeguchi, Naomi Kobayashi, Akemi Sato, ○Yuji Takeda, Shinya Kimura, Naoko Sueoka-Aragane
  
• Potential predictive markers for re-challenge with first generation and second generation EGFR-TKI;　2015
  ANNOUNCEMENT INFO.;　16th World Conference on Lung Cancer, 2015.9.6-9
  AUTHOR;　Tomomi Nakamura, Akemi Sato, Naomi Kobayashi, Hitomi Umeguchi, Kazutoshi Komiya, Shinya Kimura, Naoko Aragane
  
• A case with cancer of unknown primary diagnosed pathologically retroperitoneal squamous cell carcinoma.;　2015
  ANNOUNCEMENT INFO.;　73th Annual Meeting of the Japanese Cancer Association, 2014.9.25-27
  AUTHOR;　Hiroaki Kitamura, Tomomi Kashiwada, Kazutoshi Komiya, YukihikoNakayma, Takahiko Nakazono, Yukari Takase, Naoko Aragane, Shinya Kimura
  
• Monitoring EGFR T790M with plasma DNA in lung cancer patients treated with EGFR tyrosine kinase inhibitor in prospective observation study.;　2014
  ANNOUNCEMENT INFO.;　The 40th Annual Meeting of Korean Cancer Association, June 19-20, 2014
  AUTHOR;　Aragane N
  
• Volume-based response evaluations with consensual lesion selection using cloud solutions in clinical trials: a pilot study;　2014
  ANNOUNCEMENT INFO.;　2014 ASCO Annual Meeting, May 30 - June 3, 2014
  AUTHOR;　Estanislao Oubel, Eric Bonnard, Sueoka-Aragane N, Kobayashi N, C.Charbonnier, Yamamichi J, Mizobe H, Kimura S
  
• Usefulness of peripheral blood for monitoring of acquired resistance to EGFR tyrosine kinase inhibitors in non-small cell lung cancer;　2014
  ANNOUNCEMENT INFO.;　American Association for Cancer Research Annual Meeting 2014, April 5-9, 2014
  AUTHOR;　Kobayashi N,Sueoka-Aragane N,Umeguchi H,Nakamura T,Sato A,Komiya K, Takeda Y,Hayashi S, Sueoka E, Kimura S
  
• Monitoring of metastasis by detection of EGFR mutation, T790M, with plasma using animal model for metastasis of human lung cancer;　2014
  ANNOUNCEMENT INFO.;　2014 ASCO Annual Meeting, May 30 - June 3, 2014
  AUTHOR;　Sueoka-Aragane N,Katakami N, Satouchi M, Yokota S, Aoe K, Iwanaga K, Otsuka K,Kimura S, Negoro S
  
• Non-invasive monitoring system for acquired resistance to EGFR-tyrosine kinase inhibitors using circulating plasma DNA;　2014
  ANNOUNCEMENT INFO.;　The 73th Annual Meeting of the Japanese Cancer Association, September 25-27, 2014
  AUTHOR;　Sueoka-Aragane N,Nakamura T,Sato A,Kobayashi N,Iwanaga K,Komiya K, Hosomi T, Hirai M,Sueoka E,Okada S,Kimura S
  
• Monitoring of EGFR T790M with plasma in lung cancer patients;　2014
  ANNOUNCEMENT INFO.;　ESMO 2014 Congress, September 26-30, 2014.
  AUTHOR;　Urata Y,Sueoka-Aragane N, Katakami N, Satouchi M,Yokota S, Aoe K, Iwanaga K, Otsuka K, KimuraS,Negoro S
  
• Three cases of hemodialysis patients with advanced gastric cancer treated with Paclitaxel and nab paclitaxel;　2014
  ANNOUNCEMENT INFO.;　The 12th Annual Meeting of JSMO, 2014.7.17-19
  AUTHOR;　Kashiwada　T、Aragane　N、Kimura　S
  
• Diffuse bone marrow uptake of FDG in a patient with aleukemic acute lymphoblastic leukemia;　2014
  ANNOUNCEMENT INFO.;　The 5th JSH International Symposium 2014, 2014,5,24-25
  AUTHOR;　Kitamura H,Ando T,Kojima K,Kamachi K,Yoshihara M,Shindo T,Kubota Y,Komiya K,Sueoka-Aragane N, Sueoka E, Kimura S
  
• Usefulness of peripheral blood for monitoring of acquired resistance to EGFR tyrosine kinase inhibitors.;　2014
  ANNOUNCEMENT INFO.;　
  AUTHOR;　Kobayashi N, Sueoka-Aragane N, Nakamura T, Sato A, Komiya K, Sueoka E, Kimura S
  
• SPARC, as a possible predictive marker for albumin-bound paclitaxel in non-small cell lung cancer;　2014
  ANNOUNCEMENT INFO.;　The 73th Annual Meeting of the Japanese Cancer Association, September 25-27, 2014
  AUTHOR;　Komiya K, Sueoka-Aragane N, Kobayashi N, Sato A, Nakamura T, Hayash S,Kimura S
  
• Correlation between plasma DNA and tumor status in an animal model on metastasis of lung cancer;　2014
  ANNOUNCEMENT INFO.;　The 73th Annual Meeting of the Japanese Cancer Association, September 25-27, 2014
  AUTHOR;　Sato A,Sueoka-Aragane N, Kobayashi N,Nagano Y,Sueoka E,Okada S,Kimura S
  
• A non-invasive system for monitoring resistance to EGFR tyrosine kinase inhibitors with plasma DNA.;　2011/10
  ANNOUNCEMENT INFO.;　70th Annual Meeting of the Japanese Cancer Association　October 3-5,2011
  AUTHOR;　Aragane N , Nakamura T , Iwanaga K , Sato A , Komiya K , Ureshino N , Hosomi T , Hirai M , Sueoka E , Kimura S
  
• Mina53, a Target Gene of C-Myc, is Favorable Prognostic Marker in Early Stage Lung Cancer.;　2011/09
  ANNOUNCEMENT INFO.;　2011 European Multidisciplinary Cancer Congress　2011.9.23-27
  AUTHOR;　Komiya K , Sueoka-Aragane N , Sato A , Hayashi S , Tsuneoka M , Kimura S , Sueoka E
  
• A non-invasive system for monitoring resistance to EGFR tyrosine kinase inhibitors with plasma DNA.;　2011/09
  ANNOUNCEMENT INFO.;　The 2nd World Congress on Biomarker,　September 12-14,2011
  AUTHOR;　Sueoka-Aragane N , Nakamura T , Iwanaga K , Sato A , Komiya K , Abe T , Ureshino N , Hayashi S , Hosomi T , Hirai M , Sueoka E , Kimura S
  
• A non-invasive system for monitoring resistance to EGFR tyrosine kinase inhibitors with plasma DNA.;　2011/07
  ANNOUNCEMENT INFO.;　14th world conference on lung cancer　2011.7.3-7
  AUTHOR;　Nakamura T, Sueoka-Aragane N, Iwanaga K, Sato A, Komiya K, Abe T, Ureshino N, Hayashi S, Sueoka E, Kimura S
  
• A non-invasive system for monitoring resistance to EGFR tyrosine kinase inhibitors with plasma DNA.;　2011/07
  ANNOUNCEMENT INFO.;　The 9th Annual Meeting of Japanese Society of Medical Oncology,　July 21-23,2011
  AUTHOR;　Nakamura T , Aragane N , Komiya K , Sueoka E , Kimura S
  
• Fully automated detection system of EGFR mutation, T790M with plasma DNA of lung cancer patients.;　2011/07
  ANNOUNCEMENT INFO.;　The 14th World Conference on Lung Cancer　July 3-7,2011
  AUTHOR;　Nakamura T , Sueoka-Aragane N , Iwanaga K , Sato A , Komiya K , Abe T , Ide M , Ureshino N , Hayashi S , Sueoka E , Kimura S
  
• A Phase II Study of Erlotinib in Japanese EGFR Mutation Positive Patients with Pretreated Non-Small Cell Lung Cancer (NSCLC):Lung Oncology Group in Kyushu, Japan (LOGiK0803).;　2011/07
  ANNOUNCEMENT INFO.;　The 14th World Conference on Lung Cancer　July 3-7,2011
  AUTHOR;　Yamada K, Kawakami S, Saruwatari K, Morinaga R, Izumi M, Aragane N, Nagata S, Kishimoto J, Takayama K, Ichinose Y
  
• A non-invasive system for monitoring resistance to EGFR tyrosine kinase inhibitors with plasma DNA.;　2011/06
  ANNOUNCEMENT INFO.;　2010 ASCO Annual Meeting　2011.6.1-5
  AUTHOR;　Nakamura T, Sueoka-Aragane N, Iwanaga K, Sato A, Komiya K, Abe T, Ureshino N, Hayashi S, Sueoka E, Kimura S
  
• A non-invasive system for monitoring resistance to EGFR tyrosine kinase inhibitors with plasma DNA.;　2011/06
  ANNOUNCEMENT INFO.;　2011 American Society of Clinical Oncology,　June 1-5,2011
  AUTHOR;　Nakamura T , Sueoka-Aragane N , Iwanaga K , Sato A , Komiya K , Abe T , Ureshino N , Hayashi S , Sueoka E , Kimura S
  
• An Analysis Of Prognostic Factor For Diffuse Alveolar Hemorrhage Patients;　2011/05
  ANNOUNCEMENT INFO.;　American Thoracic society International conference 2011 in Denver　2011,5,13-18
  AUTHOR;　Abe T , Takahashi K , Kato G , Kobayashi N , Komiya K , Aragane-Sueoka N , Hayashi S
  
• Gene regulation induced by constitutive expression of hypoxia-inducible factor-1a in lymphocytes of transgenic mice.;　2011/04
  ANNOUNCEMENT INFO.;　American Association for Cancer Research 102nd Annual Meeting,　April 2-6,2011
  AUTHOR;　Ide M , Sueoka-Aragane N , Sato A , Nakamura T , Yokoo M , Hiyama K , Kimura S , Tanimoto K , Sueoka E
  
• Fully automated detection system of EGFR mutation, T790M with plasma DNA of lung cancer patients.;　2011/04
  ANNOUNCEMENT INFO.;　American Association for Cancer Research 102nd Annual Meeting　April 2-6,2011
  AUTHOR;　Sueoka-Aragane N , Nakamura T , Iwanaga K , Sato A , Komiya K , Abe T , Ide M , Ureshino N , Hayashi S , Sueoka E , Kimura S
  
• Dual targeting therapy on topoisomerase IIa and DNA-dependent protein kinase is a promising strategy for adult T cell leukemia-lymphoma.;　2011/02
  ANNOUNCEMENT INFO.;　Ｔhe 10th Japan-Korea Joint symposium on Cancer and Ageing Research　February 14-15,2011
  AUTHOR;　Hisatomi T , Aragane N , Sato A , Ide M , Okamoto K , Kimura S , Sueoka E
  
• A non-invasive system for monitoring resistance to EGFR tyrosine kinase inhibitors with plasma DNA.;　2011/02
  ANNOUNCEMENT INFO.;　The 10th Japan-Korea Joint symposium on Cancer and Ageing Research　February 14-15,2011
  AUTHOR;　Sueoka-Aragane N , Nakamura T , Iwanaga K , Sato Akemi , Komiya K , Abe T , Ide M , Ureshino N , Hayashi S , Sueoka E , Kimura S
  
• Mina53, a novel c-Myc target gene, is a favorable prognostic marker in early stage lung cancer;　2010/09
  ANNOUNCEMENT INFO.;　 69th Annual Meeting of the Japanese Cancer Association 2010年9月22-24日
  AUTHOR;　Komiya　K,　Sueoka-Aragane N, Sato A, Hayashi S, Tsuneoka M, Kimura S, Sueoka E.
  
• Fully automated detection system of EGFR mutation, T790M with plasma DNA of lung cancer patients.;　2010/09
  ANNOUNCEMENT INFO.;　69th Annual Meeting of the Japanese Cancer Association 2010年9月22-24日
  AUTHOR;　Nakamura　T, Sueoka-Aragane N, Iwanaga K, Sato A, Komiya K, Abe T, Ide M, Ureshino N, Hayashi S, Sueoka E, Kimura S
  
• Constitutive expression of Hypoxia-inducible factor-a alpha induced tumor development in a transgenic mouse.;　2010/09
  ANNOUNCEMENT INFO.;　69th Annual Meeting of the Japanese Cancer Association 2010年9月22-24日oosaka
  AUTHOR;　Sueoka E, Aragane N, Satoh A, Nakamura H, Hiyama K, Hisatomi T, Tanimoto K
  
• Tumor development in transgenic mice constitutively expressing hypoxia-inducible factor-1?;　2010/04
  ANNOUNCEMENT INFO.;　American Association for Cancer Research Annual Meeting 2010, 2010年4月17-21日
  AUTHOR;　Ide M, Sueoka E, Aragane N, Sato A, Nakamura T, Nakamura H, Hiyama K, Tanimoto K.
  
• A novel c-Myc target gene, Mina53, is a favorable prognostic marker in early stage of lung cancer;　2010/04
  ANNOUNCEMENT INFO.;　American Association for Cancer Research　101st Annual Meeting 2010年4月17-21日
  AUTHOR;　Komiya K, Sueoka-Aragane N, Sato A, Hayashi S,Tsuneoka M, Kimura S, Sueoka E
  
• Tumor susceptibility induced by constitutive expression of hypoxia-inducible factor-1a in a transgenic mouse model;　2009/12
  ANNOUNCEMENT INFO.;　
  AUTHOR;　
  
• Tumor development in transgenic mice constitutively expressing hypoxia-inducible factor-1a;　2009/12
  ANNOUNCEMENT INFO.;　The 7th Annual Meeting for the Japanese Association for Cancer and Hypoxia Research,日本癌学会シンポジウム共催　2009年12月5-6日　
  AUTHOR;　○Sueoka E, Aragane N, Sato A, Nakamura H, Hiyama K, Ide M, Kimura S, Tanimoto K
  
• Inhibition of AKT/PKB pathway as a therapeutic target for adult T cell leukemia.;　2009/10
  ANNOUNCEMENT INFO.;　68th Annual Meeting of the Japanese Cancer Association　2009年10月 1-3日
  AUTHOR;　○Hisatomi T, Tomimasu R, Aragane N, Sato A, Okamoto K, Sueoka E
  
• DNA-PK is a new therapeutic target for adult T cell leukemia/lymphoma.;　2009/04
  ANNOUNCEMENT INFO.;　American Association for Cancer Research Annual Meeting 2009　2009年4月18-22日
  AUTHOR;　○Hisatomi T, Tomimasu R, Aragane N, Sato A, Komiya K, Sueoka E.
  
• Mina53, a new candidate gene in lung carcinogenesis, exhibited oncogenic potential and induced expression of EGF receptor and HGF genes.;　2009/04
  ANNOUNCEMENT INFO.;　American Association for Cancer Research Annual Meeting 2009　2009年4月18-22日
  AUTHOR;　Komiya K, Aragane N, Satoh A, Tomimasu R, Hisatomi T, Hayashi S, Tsuneoka M, Sueoka E
  
• Myc target gene, mina53, a role in lung carcinogenesis.;　2009/04
  ANNOUNCEMENT INFO.;　American Association for Cancer Research Annual Meeting 2009　2009年4月18-22日
  AUTHOR;　Komiya K, Aragane N, Satoh A, Tomimasu R, Hisatomi T, Hayashi S, Tsuneoka M, Sueoka E
  
• Constitutive expression of Hypoxia-inducible factor-alpha induced tumor development in a transgenic mouse;　2009
  ANNOUNCEMENT INFO.;　
  AUTHOR;　○Sueoka E, Aragane N, Satoh A, Nakamura H, Hiyama K, Hisatomi T, Tanimoto K
  
• Myc target gene, mina53, a role in lung carcinogenesis;　2008/11
  ANNOUNCEMENT INFO.;　67th Annual Meeting of the Japanese Cancer Association　October 28-30, 2008
  AUTHOR;　Kazutoshi Komiya, Naoko Aragane, Akemi Satoh, Rika Tomimasu, Takashi Hisatomi, Shinichiro Hayashi, Makoto Tsuneoka, Eisaburo Sueoka
  
• A new therapeutic approach for adult T cell leukemia/lymphoma by inhibition of DNA repair system.;　2008/10
  ANNOUNCEMENT INFO.;　67th Annual Meeting of the Japanese Cancer Association　October 28-30, 2008
  AUTHOR;　Takashi Hisatomi, Rika Tomimasu, Naoko Aragane, Akemi Sato, Kazutoshi Komiya, Eisaburo Sueok
  
• Exon 19 of EGFR mutation in relation to the CA-repeat polymorphism in intron 1.;　2008/04
  ANNOUNCEMENT INFO.;　American Association for Cancer Research Annual Meeting　2008/4/15
  AUTHOR;　Aragane N, Imai K, Komiya K, Sato A, Tomimasu R, Hisatomi T, Sakuragi T, Mitsuoka M, Hayashi S, Nakachi K, Sueoka E
  
• NK314 as a new therapeutic agent for adult T cell leukemia.;　2008/04
  ANNOUNCEMENT INFO.;　American Association for Cancer Research Annual Meeting　2008/4/15
  AUTHOR;　Hisatomi T, Tomimasu R, Aragane N, Sato A, Komiya K, Sueoka E
  
• Basic study of cancer preventions by plant metabolites:(-) Epigallocatechin gallate (EGCG), green tea extract and cryptoporic acid E;　1996
  ANNOUNCEMENT INFO.;　Proc. Natl. Workshop "The benefit of traditional foods"
  AUTHOR;　Fujiki H, Suganuma M, Okabe S, Komori A, Sueoka E, Sueoka N, Kozu T, Sakai Y
  

Review Articles

• Dysautonomia associated with immune checkpoint inhibitors;　2023/07
  ANNOUNCEMENT INFO.;　J Neurol, 270, 7, 3413-3423
  AUTHOR;　*Tezuka T, Okuzumi S, Nakashima C, Ide T, Imai S, Mitsuboshi S, Kuwahara Y, Takizawa T, Seki M, Minematsu N, Aragane N, Nakahara J, Hori S, Nakane S, Suzuki S
  

Invited Lecture, Special Lecture

• Current achievement and future perspective of genome profiling by liquid biopsy;　2021/11
  ANNOUNCEMENT INFO.;　KATRDIC 2021 (Hybrid conference), 2021,11,11-12
  AUTHOR;　Aragane N
  
• Optimal Consideration for Maximal Clinical Benefits in Various EGFR-mutant Populations ;　2021/10
  ANNOUNCEMENT INFO.;　SATR Forum -The Taiwan Lung Cancer Society, 2021,10,30-31
  AUTHOR;　Aragane N
  
• Circulating tumor DNA and tumor progression;　2018
  ANNOUNCEMENT INFO.;　Anti-Cancer Treatment Japan, 2018, 5,18-19
  AUTHOR;　Aragane N
  
• Combination of liquid biopsy and re-biopsy for identification of genetic alterations related with acquired resistance to EGFR-TKI;　2018
  ANNOUNCEMENT INFO.;　Anti-Cancer Treatment Japan, 2018, 5,18-19
  AUTHOR;　Aragane N
  
• Circulating tumor DNA and tumor progression;　2018
  ANNOUNCEMENT INFO.;　The 14th Japan-Korea Joint Symposium on Cancer and Ageing Research, 2018, 5, 31- 6,2
  AUTHOR;　Aragane N